image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
74079524d50956cdc7bd70f70607916a82fb2e0783a1bdde68ee3c7ae1ecb7a7.png | simple | <table><tr><td>Norm Method</td><td>% Correct</td><td>Sensitivity</td><td>Specificity</td><td>Between-mean array correlation (after normalization)</td><td>Between array coefficient of variation (after normalization)</td><td>Confounding index (after normalization)</td></tr><tr><td>SGM-Log2</td><td>0.709</td><td>0.411</td... | <table><tr><td>Norm Method</td><td>% Correct</td><td>Sensitivity</td><td>Specificity</td><td>Between-mean array correlation (after normalization)</td><td>Between array coefficient of variation (after normalization)</td><td>Confounding index (after normalization)</td></tr><tr><td>SGM-Log2</td><td>0.709</td><td>0.411</td... | <table><tr><td>Norm Method</td><td>% Correct</td><td>Sensitivity</td><td>Specificity</td><td>Between-mean array correlation (after normalization)</td><td>Between array coefficient of variation (after normalization)</td><td>Confounding index (after normalization)</td></tr><tr><td>SGM-Cond Log Trans</td><td>0.36</td><td>... |
612b20fac8112cdc74e0e4b9f7b801475479d6973800ee72226e83497fc744be.png | simple | <table><tr><td></td><td>Cases</td><td>Deaths</td></tr><tr><td>Cervical cancer</td><td>1344</td><td>492</td></tr><tr><td>CIN2+</td><td>4528</td><td>–</td></tr><tr><td>CIN1</td><td>2532</td><td>–</td></tr><tr><td>Vaginal cancer</td><td>14</td><td>4</td></tr><tr><td>Vulvar cancer</td><td>20</td><td>6</td></tr>... | <table><tr><td></td><td>Cases</td><td>Deaths</td></tr><tr><td>Cervical cancer</td><td>1344</td><td>492</td></tr><tr><td>CIN2+</td><td>4528</td><td>–</td></tr><tr><td>CIN1</td><td>2532</td><td>–</td></tr><tr><td>Vaginal cancer</td><td>14</td><td>4</td></tr><tr><td>Vulvar</td><td></td><td>6</td></tr></table> | <table><tr><td> cancer</td><td>20</td><td></td></tr><tr><td>Anal cancer females</td><td>242</td><td>75</td></tr><tr><td>Anal cancer males</td><td>79</td><td>34</td></tr><tr><td>Genital warts females</td><td>33,091</td><td>–</td></tr><tr><td>Genital warts males</td><td>24,258</td><td>–</td></tr><tr><td>Total</td><td>66,... |
a16508fba94fcd291285896604bb41179ae0bdcf2f8c835293bcc176c7bf9f47.png | complex | <table><tr><td rowspan="3" colspan="2">Herd-level performance indicators</td><td colspan="7">Semesters</td></tr><tr><td>Jan-Jun 2009</td><td>Jul-Dec 2009</td><td>Jan-Jun 2010</td><td>Jul-Dec 2010</td><td>Jan-Jun 2011</td><td>Jul-Dec 2011</td><td>Jan-Jun 2012</td></tr><tr><td>(<i>n</i> = 710)</td><td>(<i>n</i> = 620)</t... | <table><tr><td rowspan="3" colspan="2">Herd-level performance indicators</td><td colspan="7">Semesters</td></tr><tr><td>Jan-Jun 2009</td><td>Jul-Dec 2009</td><td>Jan-Jun 2010</td><td>Jul-Dec 2010</td><td>Jan-Jun 2011</td><td>Jul-Dec 2011</td><td>Jan-Jun 2012</td></tr><tr><td>(n = 710)</td><td>(n = 620)</td><td>(n = 726... | <table><tr><td rowspan="3" colspan="2">Herd-level performance indicators</td><td colspan="7">Semesters</td></tr><tr><td>Jan-Jun 2009</td><td>Jul-Dec 2009</td><td>Jan-Jun 2010</td><td>Jul-Dec 2010</td><td>Jan-Jun 2011</td><td>Jul-Dec 2011</td><td>Jan-Jun 2012</td></tr><tr><td>(n = 710)</td><td>(n = 620)</td><td>(n = 726... |
f9b69f57bd7749d3d020fa1775a688a53c7acd642d1ecb9db5babbae5821246f.png | complex | <table><tr><td rowspan="2">Drink tea</td><td rowspan="2">Term (<i>n</i>)</td><td colspan="2">Preterm (<i>n</i> = 1019)</td><td colspan="2">Moderate preterm (<i>n</i> = 833)</td><td colspan="2">Very preterm (<i>n</i> = 186)</td><td colspan="2">Medically indicated (<i>n</i> = 338)</td><td colspan="2">Spontaneous (<i>n</i... | <table><tr><td rowspan="2">Drink tea</td><td rowspan="2">Term (n)</td><td colspan="2">Preterm (n = 1019)</td><td colspan="2">Moderate preterm (n = 833)</td><td colspan="2">Very preterm (n = 186)</td><td colspan="2">Medically indicated (n = 338)</td><td colspan="2">Spontaneous (n = 681)</td></tr><tr><td>No.</td><td>OR(9... | <table><tr><td>Before pregnancy</td><td>680</td><td>107</td><td>1.39(1.10–1.75)</td><td>91</td><td>1.47(1.15–1.87)</td><td>16</td><td>1.01(0.59–1.73)</td><td>36</td><td>1.24(0.82–1.88)</td><td>71</td><td>1.49(1.14–1.94)</td></tr><tr><td>During pregnancy ever</td><td>377</td><td>69</td><td>1.38(1.04–1.83)</td><td>55</td... |
d93774a34da71f92e26f9061552e6f05e62e70e25cba2a477bf0abd86b1b90b4.png | simple | <table><tr><td>Antimicrobial agents</td><td>Breakpoint for resistance (mg/L)</td><td>% Resistant</td><td>Range (mg/L)</td><td>MIC<sub>50</sub> (mg/L)</td><td>MIC<sub>90</sub> (mg/L)</td></tr><tr><td>Imipenem</td><td>≥8</td><td>100</td><td>8–128</td><td>32</td><td>64</td></tr><tr><td>Meropenem</td><td>≥... | <table><tr><td>Antimicrobial agents</td><td>Breakpoint for resistance (mg/L)</td><td>% Resistant</td><td>Range (mg/L)</td><td>MIC50 (mg/L)</td><td>MIC90 (mg/L)</td></tr><tr><td>Imipenem</td><td>≥8</td><td>100</td><td>8–128</td><td>32</td><td>64</td></tr></table> | <table><tr><td>Meropenem</td><td>≥8</td><td>99</td><td>4–128</td><td>32</td><td>64</td></tr><tr><td>Amikacin</td><td>≥64</td><td>87</td><td>0.5 – > 512</td><td>>512</td><td>>512</td></tr><tr><td>Ciprofloxacin</td><td>≥4</td><td>100</td><td>32 – > 512</td><td>>512</td><td>>512</td></tr><tr><td>Colistin</td><td>≥4</td><t... |
1932c6847d8f94842bdd9e6bf8bf72050ce8d49daa6a895289dd9243439342e9.png | simple | <table><tr><td>Year</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td></tr><tr><td>Export</td><td>9,762</td><td>9,975</td><td>9,630</td><td>9,496</td></tr><tr><td>Import</td><td>7,288</td><td>6,956</td><td>5,763</td><td>4,683</td></tr><tr><td>Net export</td><td>2,474</td><td>3,019</td><td>3,867</td><td>4,813</td>... | <table><tr><td>Year</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td></tr><tr><td>Export</td><td>9,762</td><td>9,975</td><td>9,630</td><td>9,496</td></tr><tr><td>Import</td><td>7,288</td><td>6,956</td><td>5,763</td><td>4,683</td></tr></table> | <table><tr><td>Year</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td></tr><tr><td>Net export</td><td>2,474</td><td>3,019</td><td>3,867</td><td>4,813</td></tr></table> |
7580aba22c626899f1258b13edaff941910fae57792ba6df8f2d09334348fe7c.png | complex | <table><tr><td></td><td colspan="3">Cohort<sup>a</sup></td><td colspan="3">Claimants<sup>b</sup></td></tr><tr><td></td><td>Odd Ratio<sup>*</sup></td><td colspan="2">95 % Confidence Interval</td><td>Odd Ratio<sup>*</sup></td><td colspan="2">95 % Confidence Interval</td></tr><tr><td colspan="7">Top cost percentile during... | <table><tr><td></td><td colspan="3">Cohorta</td><td colspan="3">Claimantsb</td></tr><tr><td></td><td>Odd Ratio*</td><td colspan="2">95 % Confidence Interval</td><td>Odd Ratio*</td><td colspan="2">95 % Confidence Interval</td></tr><tr><td colspan="7">Top cost percentile during 2010</td></tr><tr><td>Top 1 Percentile</td>... | <table><tr><td></td><td colspan="3">Cohorta</td><td colspan="3">Claimantsb</td></tr><tr><td></td><td>Odd Ratio*</td><td colspan="2">95 % Confidence Interval</td><td>Odd Ratio*</td><td colspan="2">95 % Confidence Interval</td></tr><tr><td colspan="7">Top cost percentile during 2011</td></tr><tr><td>Top 1 Percentile</td>... |
cf10eafb2b090d0ecdc1995aaf21a577d76e34b3179baf42be4125a83d6f021c.png | simple | <table><tr><td>Mean of self-monitored FPG values from preceding 3 days</td><td>Adjust of nocturnal basal insulin dosage (IU/day)</td></tr><tr><td><90 mg/dL (5.0 mmol/L)</td><td>−1</td></tr><tr><td>90-130 mg/dL (5.0-7.2 mmol/L)</td><td>No adjustment</td></tr><tr><td>>130 mg/dL (7.2 mmol/L)</td><td>+2</td></t... | <table><tr><td>Mean of self-monitored FPG values from preceding 3 days</td><td>Adjust of nocturnal basal insulin dosage (IU/day)</td></tr><tr><td><90 mg/dL (5.0 mmol/L)</td><td>−1</td></tr><tr><td>90-130 mg/dL (5.0-7.2 mmol/L)</td><td>No adjustment</td></tr><tr><td>>130 mg/dL (7.2 mmol/L)</td><td>+2</td></tr><tr><td>Me... | <table><tr><td>90-130 mg/dL (5.0-7.2 mmol/L)</td><td>No adjustment</td></tr><tr><td>>130 mg/dL (7.2 mmol/L)</td><td>+2</td></tr><tr><td>Mean of self-monitored postprandial values from preceding 3 days</td><td>Adjust of prandial insulin dosage (IU/day)</td></tr><tr><td><90 mg/dL (5.0 mmol/L)</td><td>−1</td></tr><tr><td>... |
3e278de93289701e86be7dd6ae3027cf7bf8bb30ac82a81ad0b248e31bf70eb0.png | complex | <table><tr><td rowspan="2">EV71 vaccine candidates </td><td rowspan="2">Adjuvant formulated </td><td colspan="2">Total IgG titers </td><td colspan="3">Western blot </td><td colspan="2">Virus neutralization titer </td></tr><tr><td>VP1-43</td><td>VP2-28</td><td>rVP1</td><td>rVP2</td><td>rVP3</td><td>EV71 (B4 E59)</td><td... | <table><tr><td rowspan="2">EV71 vaccine candidates</td><td rowspan="2">Adjuvant formulated</td></tr><tr></tr><tr><td>VP1-43</td><td>Alum</td></tr><tr><td>VP1-43</td><td>CFA/IFA</td></tr><tr><td>VP2-28</td><td>Alum</td></tr><tr><td>VP2-28</td><td>CFA/IFA</td></tr><tr><td>VP1-43/VP2-28</td><td>CFA/IFA</td></tr><tr><td>rV... | <table><tr><td colspan="2">Total IgG titers</td><td colspan="3">Western blot</td><td colspan="2">Virus neutralization titer</td></tr><tr><td>VP1-43</td><td>VP2-28</td><td>rVP1</td><td>rVP2</td><td>rVP3</td><td>EV71 (B4 E59)</td><td>CVA16 (N5079)</td></tr><tr><td>1/3200</td><td></td><td>++</td><td></td><td></td><td><1/8... |
d1ada4924a073bf06337993c2af9279de57c684f7d12e4f1598911c61994ec9a.png | complex | <table><tr><td rowspan="2">System</td><td colspan="2">Prosthetic crown</td></tr><tr><td>8 mm</td><td>13 mm</td></tr><tr><td>Neodent</td><td>31.43 ±15.44Aa</td><td>28.13 ± 12.66Aa</td></tr><tr><td>Bicon</td><td>26.18 ± 13.00Ba</td><td>30.92 ± 14.89Aa</td></tr></table> | <table><tr><td>Sys</td><td colspan="2">Prosthetic cro</td></tr></table> | <table><tr><td rowspan="2">tem</td><td colspan="2">wn</td></tr><tr><td>8 mm</td><td>13 mm</td></tr><tr><td>Neodent</td><td>31.43 ±15.44Aa</td><td>28.13 ± 12.66Aa</td></tr><tr><td>Bicon</td><td>26.18 ± 13.00Ba</td><td>30.92 ± 14.89Aa</td></tr></table> |
c6ef6855f7ecf430cc22156b65cfbde20e05187b250e6ac9e364fbdddf22eb99.png | complex | <table><tr><td></td><td>Number of patients (percentage of sample in parentheses)</td></tr><tr><td colspan="2">Age</td></tr><tr><td><=60 years</td><td>1743 (65.1%)</td></tr><tr><td>>60 years</td><td>936 (34.9%)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td>Female</td><td>1439 (53.7%)</td></tr><tr><td>Male</... | <table><tr><td></td><td>Number of patients (percentage of sample in parentheses)</td></tr><tr><td colspan="2">Age</td></tr><tr><td><=60 years</td><td>1743 (65.1%)</td></tr><tr><td>>60 years</td><td>936 (34.9%)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td>Female</td><td>1439 (53.7%)</td></tr><tr><td>Male</td><td... | <table><tr><td>Non-smoker</td><td>1914 (71.4%)</td></tr><tr><td colspan="2">Country</td></tr><tr><td>Eastern European countries</td><td>1763 (65.8%)</td></tr><tr><td>Western-central European countries</td><td>916 (34.2%)</td></tr></table> |
fc060b841b31eafeb330043db70d8efc75ae4f0fb855a57d8c0ae5f25e346760.png | complex | <table><tr><td></td><td>miR-155 copy no.</td><td>Age</td><td>DD</td><td>ESR</td><td>CRP</td><td>TJS</td><td>SJS</td></tr><tr><td rowspan="3">Age</td><td>−0.239</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(−0.58, 0.18)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr>... | <table><tr><td></td><td>miR-155 copy no.</td><td>Age</td><td>DD</td><td>ESR</td><td>CRP</td><td>TJS</td><td>SJS</td></tr><tr><td rowspan="3">Age</td><td>−0.239</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(−0.58, 0.18)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>0.26... | <table><tr><td>)</td><td>, 0.22)</td><td>44, 0.35)</td><td> 0.88)</td><td></td><td>(0.55, 0.90)</td><td>0.93)</td></tr><tr><td>0.000</td><td>0.366</td><td>0.797</td><td>0.000</td><td>0.002</td><td>0.000</td><td>0.000</td></tr></table> |
bd82304d3f88fab4b3d74c2464d42d3de5b0eecb27943c48ffca68e1feb25d74.png | simple | <table><tr><td></td><td>Intrathecal morphine (<i>n</i> = 50)</td><td>Epidural analgesia (<i>n</i> = 50)</td><td><i>P</i></td></tr><tr><td>Patients with complications</td><td>8 (16%)</td><td>11 (22%)</td><td>.59</td></tr><tr><td> Biloma</td><td>1 (2%)</td><td>1 (2%)</td><td>.89</td></tr><tr><td> Hepatic insufficiency</t... | <table><tr><td></td><td>Intrathecal morphine (n = 50)</td><td>Epidural analgesia (n = 50)</td><td>P</td></tr><tr><td>Patients with complications</td><td>8 (16%)</td><td>11 (22%)</td><td>.59</td></tr><tr><td>Biloma</td><td>1 (2%)</td><td>1 (2%)</td><td>.89</td></tr></table> | <table><tr><td></td><td>Intrathecal morphine (n = 50)</td><td>Epidural analgesia (n = 50)</td><td>P</td></tr><tr><td>Hepatic insufficiency</td><td>2 (4%)</td><td>3 (6%)</td><td>.88</td></tr><tr><td>Wound infection</td><td>3 (6%)</td><td>4 (8%)</td><td>.73</td></tr><tr><td>Pleural effusion</td><td>1 (2%)</td><td>2 (4%)<... |
655ef9ad5ea76958499cc59f1a75bf4275b59d7917f14bdb2c752a01879ffa60.png | simple | <table><tr><td></td><td>Positive likelihood ratio (95% CI)</td><td>Negative likelihood ratio (95% CI)</td></tr><tr><td>Serial ECG & ST monitoring N = 690</td><td>5.4 (3.0 to 9.8)</td><td>0.801 (0.696 to 0.922)</td></tr><tr><td>Initial CK-MB(mass) N = 687</td><td>20.9 (11.3 to 38.5)</td><td>0.579 (0.464 to 0.722)</t... | <table><tr><td></td><td>Positive likelihood ratio (95% CI)</td><td>Negative likelihood ratio (95% CI)</td></tr><tr><td>Serial ECG & ST monitoring N = 690</td><td>5.4 (3.0 to 9.8)</td><td>0.801 (0.696 to 0.922)</td></tr><tr><td>Initial CK-MB(mass) N = 687</td><td>20.9 (11.3 to 38.5)</td><td>0.579 (0.464 to 0.722)</td></... | <table><tr><td></td><td>Positive likelihood ratio (95% CI)</td><td>Negative likelihood ratio (95% CI)</td></tr><tr><td>Delta CK-MB(mass) N = 601</td><td>153.1 (37.6 to 623.5)</td><td>0.444 (0.327 to 0.602)</td></tr><tr><td>Any positive CK-MB(mass) N = 601</td><td>28.1 (16.9 to 46.7)</td><td>0.291 (0.194 to 0.435)</td><... |
691cc4c699f6b69163df8cc574ad891e6bef4e57f0ab59a8e3c3b4483b0ee630.png | simple | <table><tr><td>Molar ratio</td><td>Vitamin K recovery (%)</td><td>Lipid recovery (%)</td><td>Loading capacity (w %)</td><td>Size (nm)</td></tr><tr><td>0.22</td><td>98.4 ± 2.8</td><td>96.3 ± 0.4</td><td>5.0 ± 0.2</td><td>11.0 ± 1.4</td></tr><tr><td>0.44</td><td>91.3 ± 2.0</td><td>89.5 ± 4.1... | <table><tr><td>Molar ratio</td><td>Vitamin K recovery (%)</td><td>Lipid recovery (%)</td><td>Loading capacity (w %)</td><td>Size (nm)</td></tr><tr><td>0.22</td><td>98.4 ± 2.8</td><td>96.3 ± 0.4</td><td>5.0 ± 0.2</td><td>11.0 ± 1.4</td></tr></table> | <table><tr><td>Molar ratio</td><td>Vitamin K recovery (%)</td><td>Lipid recovery (%)</td><td>Loading capacity (w %)</td><td>Size (nm)</td></tr><tr><td>0.44</td><td>91.3 ± 2.0</td><td>89.5 ± 4.1</td><td>9.9 ± 0.2</td><td>19 ± 6</td></tr><tr><td>0.88</td><td>42.6 ± 1.5</td><td>41.1 ± 3.9</td><td>18.4 ± 0.5</td><td>44 ± 5... |
d3fea483e6f1c47fa318ff13b8977b42592863de13606049f493ae1e143f0ce8.png | complex | <table><tr><td></td><td></td><td colspan="2">TGC</td><td colspan="2">CGC</td><td rowspan="2">Overall event rates (%)</td><td colspan="2">M-H pooled RR</td><td colspan="2">Heterogeneity</td></tr><tr><td>Events</td><td>Studies</td><td>N+(%)</td><td>Total</td><td>N+(%)</td><td>Total</td><td>RR/ SMD (95%CI)</td><td><i>p</i... | <table><tr><td></td><td></td><td colspan="2">TGC</td><td colspan="2">CGC</td><td rowspan="2">Overall event rates (%)</td><td colspan="2">M-H pooled RR</td><td colspan="2">Heterogeneity</td></tr><tr><td>Events</td><td>Studies</td><td>N+(%)</td><td>Total</td><td>N+(%)</td><td>Total</td><td>RR/ SMD (95%CI)</td><td>p</td><... | <table><tr><td></td><td></td><td colspan="2">TGC</td><td colspan="2">CGC</td><td rowspan="2">Overall event rates (%)</td><td colspan="2">M-H pooled RR</td><td colspan="2">Heterogeneity</td></tr><tr><td>Events</td><td>Studies</td><td>N+(%)</td><td>Total</td><td>N+(%)</td><td>Total</td><td>RR/ SMD (95%CI)</td><td>p</td><... |
a9cf66c7ab90d6b42fca49b9ef34271b5cf84c83a195f7fc54417f99e96b578d.png | complex | <table><tr><td rowspan="2">Results of TST</td><td colspan="3">Results of T.SPOT.TB</td><td> </td></tr><tr><td>Negative</td><td>Positive</td><td>Indeterminate</td><td>Total</td></tr><tr><td>Negative</td><td>79</td><td>3</td><td>4</td><td>86</td></tr><tr><td>Positive</td><td>4</td><td>2</td><td>0</td><td>6</td></tr><tr><... | <table><tr><td rowspan="2">Results of TST</td><td colspan="3">Results of T.SPOT.TB</td><td></td></tr><tr><td>Negative</td><td>Positive</td><td>Indeterminate</td><td>Total</td></tr><tr><td>Negative</td><td>79</td><td>3</td><td>4</td><td>86</td></tr><tr><td>Positi</td><td>4</td><td></td><td></td><td></td></tr></table> | <table><tr><td>ve</td><td></td><td>2</td><td>0</td><td>6</td></tr><tr><td>Total</td><td>83</td><td>5</td><td>4</td><td>92</td></tr></table> |
a0d5a49fd6f11c8c839b63122a05b422afb4a1713103501eb477bb60673b9ed5.png | complex | <table><tr><td></td><td colspan="2">Controls</td><td colspan="2">Offspring</td></tr><tr><td></td><td>Beta ± SE †</td><td><i>P</i>-value*</td><td>Beta ± SE†</td><td><i>P</i>-value*</td></tr><tr><td>PC (O-34:3)</td><td>0.037 ± 0.322</td><td>0.909</td><td>0.034 ± 0.369</td><td>0.927</td></t... | <table><tr><td></td><td colspan="2">Controls</td><td>Offspring</td></tr><tr><td></td><td>Beta ± SE †</td><td>P-value*</td><td>Beta ± SE†</td></tr><tr><td>PC (O-34:3)</td><td>0.037 ± 0.322</td><td>0.909</td><td>0.034 ± 0.369</td></tr><tr><td>PC (O-34:1)</td><td>−0.384 ± 0.303</td><td>0.206</td><td>−0.124 ± 0.236</td></t... | <table><tr><td>Offspring</td></tr><tr><td>P-value*</td></tr><tr><td>0.927</td></tr><tr><td>0.600</td></tr><tr><td>0.345</td></tr><tr><td>0.094</td></tr><tr><td>0.356</td></tr><tr><td>0.069</td></tr><tr><td>0.136</td></tr><tr><td>0.064</td></tr><tr><td>0.996</td></tr><tr><td>0.786</td></tr><tr><td>0.186</td></tr><tr><td... |
0df99866a6d94a4b04577d09fee04ef835b6b1577db81df51489f1620c095865.png | complex | <table><tr><td>Criteria/Quantitative description</td><td>Score</td></tr><tr><td colspan="2">Background blood/clot</td></tr><tr><td>Large amount; great compromise in diagnosis</td><td>0</td></tr><tr><td>Moderate amount; diagnosis possible</td><td>1</td></tr><tr><td>Minimal; diagnosis</td><td>2</td></tr><tr><td colspan="... | <table><tr><td>Criteria/Quantitative description</td><td>Score</td></tr></table> | <table><tr><td colspan="2">Background blood/clot</td></tr><tr><td>Large amount; great compromise in diagnosis</td><td>0</td></tr><tr><td>Moderate amount; diagnosis possible</td><td>1</td></tr><tr><td>Minimal; diagnosis</td><td>2</td></tr><tr><td colspan="2">Amount of cellular material</td></tr><tr><td>Minimal to absent... |
4cbcc40629aa724635e56a40553869cf1f5d8af8853ce856fe388ca9f11f8d9f.png | complex | <table><tr><td></td><td colspan="6">Strains with Stable ST</td></tr><tr><td>Patient</td><td>ST of the first CoS strain isolated</td><td>Sample type</td><td>Sample type of first clinical CoS</td><td>ST of CoR strain isolated</td><td>Sample type</td><td>Time to switch from CoR to CoS (days)</td></tr><tr><td>1</td><td>554... | <table><tr><td></td><td colspan="6">Strains with Stable ST</td></tr><tr><td>Patient</td><td>ST of the first CoS strain isolated</td><td>Sample type</td><td>Sample type of first clinical CoS</td><td>ST of CoR strain isolated</td><td>Sample type</td><td>Time to switch from CoR to CoS (days)</td></tr></table> | <table><tr><td>1</td><td>554</td><td>SRS</td><td>Arterial catheter</td><td>-</td><td>bronchial aspirate</td><td>36</td></tr><tr><td>2</td><td>512</td><td>SRS</td><td>skin swab</td><td>-</td><td>urine</td><td>26</td></tr><tr><td>3</td><td>307</td><td>SRS</td><td>skin swab</td><td>-</td><td>skin swab</td><td>42</td></tr>... |
7c9495d3ea0482a146396e2fbcfca5f3a98bfd9b6ca339052572a1b554ac681c.png | complex | <table><tr><td rowspan="2">Variants</td><td rowspan="2">Haplotype</td><td colspan="2">Haplotype frequency</td><td rowspan="2">OR (95% CI)</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>Case (<i>n</i> = 350)</td><td>Control (<i>n</i> = 350)</td></tr><tr><td rowspan="4">eNOS 4 and eNOS 7</td><td>bG</td><td>0.5550</t... | <table><tr><td rowspan="2">Variants</td><td rowspan="2">Haplotype</td><td colspan="2">Haplotype frequency</td><td rowspan="2">OR (95% CI)</td><td rowspan="2">P value</td></tr><tr><td>Case (n = 350)</td><td>Control (n = 350)</td></tr><tr><td rowspan="4">eNOS 4 and eNOS 7</td><td>bG</td><td>0.5550</td><td>0.7912</td><td>... | <table><tr><td rowspan="4">eNOS 7 and eNOS T786C</td><td>GT</td><td>0.5698</td><td>0.7268</td><td>0.50 (0.36–0.69)</td><td>0.000∗</td></tr><tr><td>GC</td><td>0.1702</td><td>0.1932</td><td>0.86 (0.57–1.28)</td><td>0.47</td></tr><tr><td>TT</td><td>0.2002</td><td>0.0632</td><td>3.73 (2.19–6.38)</td><td>0.000∗</td></tr><tr... |
c0772a5f9fc49b52496281c362f29dd455134bfa515d6622b2eab02e5241d3d8.png | simple | <table><tr><td>Classifier</td><td>PSGO-TRN</td><td>PSGO-TST</td><td>ORI-TRN</td><td>ORI-TST</td><td>ORIRW-TRN</td><td>ORIRW-TST</td><td>Mean</td></tr><tr><td>SCMPSP</td><td>83.82</td><td>71.54</td><td>77.78</td><td>62.60</td><td>81.8</td><td>64.38</td><td>66.17</td></tr><tr><td>SVM-AAC</td><td>85.45</td><td>78.85</td><... | <table><tr><td>Classifier</td><td>PSGO-TRN</td><td>PSGO-TST</td><td>ORI-TRN</td><td>ORI-TST</td><td>ORIRW-TRN</td><td>ORIRW-TST</td></tr><tr><td>SCMPSP</td><td>83.82</td><td>71.54</td><td>77.78</td><td>62.60</td><td>81.8</td><td>64.38</td></tr><tr><td>SVM-AAC</td><td>85.45</td><td>78.85</td><td>71.36</td><td>50.61</td>... | <table><tr><td>Mean</td></tr><tr><td>66.17</td></tr><tr><td>62.25</td></tr><tr><td>67.60</td></tr><tr><td>72.52</td></tr><tr><td>62.35</td></tr><tr><td>57.53</td></tr><tr><td>66.83</td></tr><tr><td>65.74</td></tr><tr><td>61.79</td></tr><tr><td>60.68</td></tr><tr><td></td></tr></table> |
ee7311b4fc06224443850343ba2210cf74d14ccf4d2827db60df586e2b4e2573.png | complex | <table><tr><td rowspan="2">Factor</td><td colspan="2">IRR (95% CI)</td></tr><tr><td>Unadjusted</td><td>Adjusted</td></tr><tr><td>Gender</td><td> </td><td> </td></tr><tr><td>Female</td><td>1.00</td><td>1.00</td></tr><tr><td>Male</td><td>0.53 (0.45-0.61)</td><td>0.53 (0.45-0.61)</td></tr><tr><td>Age (years)</td><td> </td... | <table><tr><td rowspan="2">Factor</td><td colspan="2">IRR (95% CI)</td></tr><tr><td>Unadjusted</td><td>Adjusted</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>Female</td><td>1.00</td><td>1.00</td></tr><tr><td>Male</td><td>0.53 (0.45-0.61)</td><td>0.53 (0.45-0.61)</td></tr><tr><td>Age (years)</td><td></td><t... | <table><tr><td rowspan="2">Factor</td><td colspan="2">IRR (95% CI)</td></tr><tr><td>Unadjusted</td><td>Adjusted</td></tr><tr><td>Uppsala/Örebro</td><td>1.00 (0.78-1.27)</td><td>1.19 (0.93-1.52)</td></tr><tr><td>West</td><td>1.37 (1.07-1.74)</td><td>1.49 (1.17-1.89)</td></tr><tr><td>Abroad</td><td>0.78 (0.25-2.47)</td>... |
257780f771a5ee98928c37b95fec0d35aebb72e05b3d30f928a8e473ba737a8a.png | complex | <table><tr><td colspan="2"></td><td>Word-pairs</td><td>Sentences</td><td>Oddball</td><td>Mean per task</td></tr><tr><td>Ignore task</td><td><i>M</i></td><td>32.55</td><td>55.99</td><td>46.89</td><td>45.15</td></tr><tr><td></td><td><i>SD</i></td><td>22.08</td><td>56.99</td><td>40.52</td><td>42.66</td></tr><tr><td>Passiv... | <table><tr><td colspan="2"></td><td>Word-pairs</td><td>Sentences</td><td>Oddball</td><td>Mean per task</td></tr><tr><td>Ignore task</td><td>M</td><td>32.55</td><td>55.99</td><td>46.89</td><td>45.15</td></tr><tr><td></td><td>SD</td><td>22.08</td><td>56.99</td><td>40.52</td><td>42.66</td></tr><tr><td>Passive task</td><td... | <table><tr><td colspan="2"></td><td>Word-pairs</td><td>Sentences</td><td>Oddball</td><td>Mean per task</td></tr><tr><td></td><td>SD</td><td>47.24</td><td>58.11</td><td>55.82</td><td>53.34</td></tr><tr><td>Focused task</td><td>M</td><td>73.76</td><td>85.98</td><td>83.71</td><td>81.15</td></tr><tr><td></td><td>SD</td><td... |
04df60799f8d4d0ad1929879a99219a3a82daf2b801f0772b557391d5e55af19.png | complex | <table><tr><td></td><td>liver</td><td>spleen</td><td>caecum</td></tr><tr><td></td><td colspan="3">(log CFU/g of tissue)</td></tr><tr><td>wt</td><td>4.97 ± 2.22</td><td>5.52 ± 2.47</td><td>4.19 ± 2.49</td></tr><tr><td>ΔSPI1</td><td>5.10 ± 1.12</td><td>5.79 ± 1.07</td><td>4.18 ± 1.15</t... | <table><tr><td></td><td>liver</td><td>spleen</td><td>caecum</td></tr><tr><td></td><td colspan="3">(log CFU/g of tissue)</td></tr><tr><td>wt</td><td>4.97 ± 2.22</td><td>5.52 ± 2.47</td><td>4.19 ± 2.49</td></tr><tr><td>ΔSPI1</td><td>5.10 ± 1.12</td><td>5.79 ± 1.07</td><td>4.18 ± 1.15</td></tr><tr><td>ΔSPI2</td><td>0.25 ±... | <table><tr><td>ΔSPI5</td><td>3.52 ± 1.79</td><td>4.29 ± 2.32</td><td>2.90 ± 1.40</td></tr><tr><td>SPI1o</td><td>0.33 ± 0.47*</td><td>0.33 ± 0.47*</td><td>2.20 ± 1.59</td></tr><tr><td>SPI2o</td><td>5.29 ± 0.87</td><td>5.82 ± 1.07</td><td>3.76 ± 0.77</td></tr><tr><td>SPI3o</td><td>0.00 ± 0.00*</td><td>0.00 ± 0.00*</td><t... |
90f91e47e62f4aba434d7ce5f1b731814bfbdcbf7ad20e6095f18e10350c3940.png | simple | <table><tr><td>Area</td><td>WT TA (o)</td><td>SOD TA (o)</td><td>WT TA (i)</td><td>SOD TA (i)</td><td>WT Soleus</td><td>SOD Soleus</td></tr><tr><td>#Dock vesicles/μm AZ</td><td>5.11 ± 0.65</td><td>4.91 ± 0.65</td><td>5.67 ± 0.97</td><td>4.62 ± 0.96</td><td>5.99 ± 0.63</td><td>4.55 ± 0... | <table><tr><td>Area</td><td>WT TA (o)</td><td>SOD TA (o)</td><td>WT TA (i)</td><td>SOD TA (i)</td><td>WT Soleus</td><td>SOD Soleus</td></tr><tr><td>#Dock vesicles/μm AZ</td><td>5.11 ± 0.65</td><td>4.91 ± 0.65</td><td>5.67 ± 0.97</td><td>4.62 ± 0.96</td><td>5.99 ± 0.63</td><td>4.55 ± 0.62</td></tr><tr><td>#Vesicles/μm2 ... | <table><tr><td>Area</td><td>WT TA (o)</td><td>SOD TA (o)</td><td>WT TA (i)</td><td>SOD TA (i)</td><td>WT Soleus</td><td>SOD Soleus</td></tr><tr><td>Junctional fold diameter (nm)</td><td>65.24 ± 2.90</td><td>67.60 ± 2.88</td><td>72.014 ± 4.46</td><td>65.26 ± 4.27</td><td>79.06 ± 4.43</td><td>73.02 ± 4.30</td></tr></tabl... |
ceb81b8842f6042d07c7c6486fccd6d3a7b3c28c8e0c75271bff974939f32950.png | complex | <table><tr><td></td><td colspan="2">General Practitioner Visits</td><td></td><td colspan="2">Specialist Visits</td><td></td></tr><tr><td>Variables</td><td>Chinese N (% of 746)</td><td>White N (% of 711)</td><td>P-Value</td><td>Chinese N (% of 485)</td><td>White N (% of 637)</td><td>P-Value</td></tr><tr><td>Satisfied wi... | <table><tr><td></td><td colspan="2">General Practitioner Visits</td><td></td><td colspan="2">Specialist Visits</td><td></td></tr><tr><td>Variables</td><td>Chinese N (% of 746)</td><td>White N (% of 711)</td><td>P-Value</td><td>Chinese N (% of 485)</td><td>White N (% of 637)</td><td>P-Value</td></tr><tr><td>Satisfied wi... | <table><tr><td></td><td colspan="2">General Practitioner Visits</td><td></td><td colspan="2">Specialist Visits</td><td></td></tr><tr><td>Variables</td><td>Chinese N (% of 746)</td><td>White N (% of 711)</td><td>P-Value</td><td>Chinese N (% of 485)</td><td>White N (% of 637)</td><td>P-Value</td></tr><tr><td>Definitely t... |
6d155b4d3e1d9bbb16d7f360416839b84c6a6d1968298c4f6d21fc110db46c8f.png | complex | <table><tr><td colspan="2">Cost in CDN dollars Mean (SD)</td></tr><tr><td>Total Cost</td><td>$49,923 (45,773)</td></tr><tr><td>Total Indirect Cost</td><td>$13,566 (12,625)</td></tr><tr><td>Total Direct Cost</td><td>$36,358 (33,501)</td></tr><tr><td colspan="2">Direct Costs per costing Category</td></tr><tr><td> Health ... | <table><tr><td colspan="2">Cost in CDN dollars Mean (SD)</td></tr><tr><td>Total Cost</td><td>$49,923 (45,773)</td></tr><tr><td>Total Indirect Cost</td><td>$13,566 (12,625)</td></tr><tr><td>Total Direct Cost</td><td>$36,358 (33,501)</td></tr><tr><td colspan="2">Direct Costs per costing Category</td></tr><tr><td>Health P... | <table><tr><td>Nursing</td><td>$16,378 (16,735)</td></tr><tr><td>Operating room</td><td>$1192 (1819)</td></tr><tr><td>Surgical Implants</td><td>$907 (2821)</td></tr><tr><td>Post anaesthesia care unit</td><td>$307 (590)</td></tr><tr><td>Pharmacy</td><td>$3273 (4157)</td></tr><tr><td>Special Care Unit</td><td>$7502 (16,9... |
56eb2fe0c4ba77a0411b6bc689a7809a63293d59cc4e20726183dcfe97cf7fcc.png | simple | <table><tr><td>Variables</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Age (yr)</td><td>21.5 ± 2.6</td><td>18.0~25.0</td></tr><tr><td>Height (cm)</td><td>175.5 ± 6.0</td><td>167.0~185.0</td></tr><tr><td>Weight (kg)</td><td>94.9 ± 12.9</td><td>79.3~117.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td... | <table><tr><td>Variables</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Age (yr)</td><td>21.5 ± 2.6</td><td>18.0~25.0</td></tr><tr><td>Height (cm)</td><td>175.5 ± 6.0</td><td>167.0~185.0</td></tr></table> | <table><tr><td>Variables</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Weight (kg)</td><td>94.9 ± 12.9</td><td>79.3~117.4</td></tr><tr><td>BMI (kg/m2)</td><td>30.7 ± 2.6</td><td>27.4~34.3</td></tr><tr><td>LBM (kg)</td><td>74.4 ± 8.7</td><td>62.1~90.9</td></tr><tr><td>FM (kg)</td><td>16.4 ± 5.8</td><td>9.7~27.0</td><... |
38068945230b7a9dbc00ea2a778ee8eaa3a7b1ae3f7ee08fdc782610647e9c0a.png | complex | <table><tr><td>Variables</td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td><td><i>P</i> value</td></tr><tr><td colspan="6">Demographics</td></tr><tr><td>(<i>n</i> = 4,970)</td><td>(<i>n</i> = 1,347)</td><td>(<i>n</i> = 1,356)</td><td>(<i>n</i> = 1,150)</td><td>(<i>n</i> = 1,117)</td><td></... | <table><tr><td>Variables</td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td></tr><tr><td colspan="4">Demographics</td></tr><tr><td>(n = 4,970)</td><td>(n = 1,347)</td><td>(n = 1,356)</td><td>(n = 1,150)</td></tr><tr><td>Age, in years</td><td>56.5 (8.6)</td><td>59.7 (9.3)</td><td>63.4 (9.3)</td></tr><tr><td>Ma... | <table><tr><td>Quartile 4</td><td>P value</td></tr><tr><td colspan="2">Demographics</td></tr><tr><td>(n = 1,117)</td><td></td></tr><tr><td>67.8 (9.6)</td><td><0.0001</td></tr><tr><td>591 (53%)</td><td><0.0001</td></tr><tr><td>526 (47%)</td><td><0.0001</td></tr><tr><td>501 (45%)</td><td><0.0001</td></tr><tr><td>116 (10%... |
306c4d855d432f8d7d66b4a5f981dbbac3effab57dee4429b198bb5161a34eef.png | complex | <table><tr><td>Factor</td><td>Univariable HR</td><td><i>p</i>-value</td><td>Multivariable HR (95% CI)</td><td><i>p</i>-value</td></tr><tr><td colspan="5">Monitoring randomisation</td></tr><tr><td> LCM</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td></tr><tr><td> CDM</td><td>1.07</td><td>0.45</td><td>1.11 (0.93 - 1.35... | <table><tr><td>Factor</td><td>Univariable HR</td><td>p-value</td><td>Multivariable HR (95% CI)</td><td>p-value</td></tr><tr><td colspan="5">Monitoring randomisation</td></tr><tr><td>LCM</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td></tr><tr><td>CDM</td><td>1.07</td><td>0.45</td><td>1.11 (0.93 - 1.35)</td><td>0.25</... | <table><tr><td>Factor</td><td>Univariable HR</td><td>p-value</td><td>Multivariable HR (95% CI)</td><td>p-value</td></tr><tr><td>TDF</td><td>1.00</td><td><0.0001</td><td>1.00</td><td><0.0001</td></tr><tr><td>NVP</td><td>0.49</td><td>-</td><td>0.48 (0.38 - 0.62)</td><td>-</td></tr><tr><td>ABC</td><td>1.18</td><td>-</td><... |
cf4e56613021fe95f39b5b3b46cbdef806cc50bc88650d57c6c2860c1ccdb7ea.png | simple | <table><tr><td>Method</td><td>Planar objects</td><td>Real feet</td><td>Main disadvantages</td></tr><tr><td> </td><td>Accuracy/Repeatibility</td><td>Static/Dynamic</td><td> </td></tr><tr><td>Coudert <i>et al.</i>[13]</td><td>NA/NA</td><td>NA/NA</td><td>Technique requires spraying foot with paint or adding sock</td></tr>... | <table><tr><td>Method</td><td>Planar objects</td><td>Real feet</td><td>Main disadvantages</td></tr><tr><td></td><td>Accuracy/Repeatibility</td><td>Static/Dynamic</td><td></td></tr><tr><td>Coudert et al.[13]</td><td>NA/NA</td><td>NA/NA</td><td>Technique requires spraying foot with paint or adding sock</td></tr><tr><td>J... | <table><tr><td>Mochimaru et al.[20]</td><td>NA/NA</td><td>NA/NA</td><td>Matching random pattern is computationally expensive and can create unpredictable errors</td></tr><tr><td>Yoshida & Kouchi [21]</td><td>NA/NA</td><td>4.0 mm/NA</td><td>System uses one generic model for all foot reconstructions; shape deformations d... |
cb604686ec2ab9529f30bb181c7fdebe00d5966b15eeb93b7aab93e2afd30ec6.png | simple | <table><tr><td></td><td>CFS</td><td>Healthy</td></tr><tr><td></td><td>(n = 55)</td><td>(n = 30)</td></tr><tr><td>Age (y)</td><td>35.4 ± 1.1</td><td>36.1 ± 1.6</td></tr><tr><td>Male</td><td>20</td><td>11</td></tr><tr><td>Female</td><td>35</td><td>19</td></tr><tr><td>α-MSH (pg/mL)</td><td>17.9 ± 1.0</... | <table><tr><td></td><td>CFS</td><td>Healthy</td></tr><tr><td></td><td>(n = 55)</td><td>(n = 30)</td></tr><tr><td>Age (y)</td><td>35.4 ± 1.1</td><td>36.1 ± 1.6</td></tr></table> | <table><tr><td></td><td>CFS</td><td>Healthy</td></tr><tr><td></td><td>(n = 55)</td><td>(n = 30)</td></tr><tr><td>Male</td><td>20</td><td>11</td></tr><tr><td>Female</td><td>35</td><td>19</td></tr><tr><td>α-MSH (pg/mL)</td><td>17.9 ± 1.0</td><td>14.5 ± 1.0*</td></tr></table> |
3615f4b380631ae8ee09a2574346c86c351270105eca535496870eaf78274bfe.png | complex | <table><tr><td>Response to endotoxin administration</td><td>Clinical</td><td>Autonomic</td><td colspan="4">Immune</td></tr><tr><td>Outcome expectancies</td><td>Flu-like symptoms (T90)</td><td>Epinephrine (T0)</td><td>IL-10 (T60)</td><td>TNF-α (T90)</td><td>IL-6 (T120)</td><td>IL-8 (T120)</td></tr><tr><td colspan="... | <table><tr><td>Response to endotoxin administration</td><td>Clinical</td><td>Autonomic</td><td colspan="4">Immune</td></tr><tr><td>Outcome expectancies</td><td>Flu-like symptoms (T90)</td><td>Epinephrine (T0)</td><td>IL-10 (T60)</td><td>TNF-α (T90)</td><td>IL-6 (T120)</td><td>IL-8 (T120)</td></tr><tr><td colspan="7">Ge... | <table><tr><td>Response to endotoxin administration</td><td>Clinical</td><td>Autonomic</td><td colspan="4">Immune</td></tr><tr><td>Outcome expectancies</td><td>Flu-like symptoms (T90)</td><td>Epinephrine (T0)</td><td>IL-10 (T60)</td><td>TNF-α (T90)</td><td>IL-6 (T120)</td><td>IL-8 (T120)</td></tr><tr><td>Optimism (LOT-... |
10ed6dc043f222f86f8c5921871ff6def4c57edfa6dda79c55304dba121158bc.png | complex | <table><tr><td>Surfactant</td><td>Drug loaded</td><td>Comments</td><td>References</td></tr><tr><td>Brij 35, 78, 98, and 700</td><td>Atenolol, timolol, betaxololcyclosporine A</td><td>Significantly increased the corneal permeability.Significantly increased bioavailability of ophthalmic drugs by using contact lenses.</td... | <table><tr><td>Surfactant</td><td>Drug loaded</td><td>Comments</td></tr><tr><td>Brij 35, 78, 98, and 700</td><td>Atenolol, timolol, betaxololcyclosporine A</td><td>Significantly increased the corneal permeability.Significantly increased bioavailability of ophthalmic drugs by using contact lenses.</td></tr><tr><td>Polys... | <table><tr><td>References</td></tr><tr><td>[52, 76]</td></tr><tr><td>[71]</td></tr><tr><td>[68]</td></tr><tr><td>[72]</td></tr><tr><td>[23, 25]</td></tr><tr><td>[45, 46]</td></tr><tr><td>[67]</td></tr><tr><td>[43, 45, 73]</td></tr><tr><td>[77–80]</td></tr><tr><td>[74]</td></tr><tr><td>[25]</td></tr><tr><td>[75]</td></t... |
a30164d64430187532573aed060100999ce5e0f5b99aac4470f146ca18cc84b2.png | simple | <table><tr><td>Expression</td><td>Gene_Symbol</td><td>LogFC</td><td>Adjusted <i>p</i> value</td></tr><tr><td>Upregulated</td><td>Grin2c</td><td>2.272</td><td>4.27E−06</td></tr><tr><td></td><td>Ccnb3</td><td>3.243</td><td>4.27E−06</td></tr><tr><td></td><td>Usp51</td><td>1.702</td><td>4.45E−06</td></tr>... | <table><tr><td>Expression</td><td>Gene_Symbol</td><td>LogFC</td><td>Adjusted p value</td></tr><tr><td>Upregulated</td><td>Grin2c</td><td>2.272</td><td>4.27E−06</td></tr><tr><td></td><td>Ccnb3</td><td>3.243</td><td>4.27E−06</td></tr><tr><td></td><td>Usp51</td><td>1.702</td><td>4.45E−06</td></tr><tr><td></td><td>Slc1a3</... | <table><tr><td>Atp10a</td><td>− 1.118</td><td>1.85E−05</td></tr><tr><td>Slc6a15</td><td>− 2.051</td><td>1.85E−05</td></tr></table> |
865ba1306ed73d847c1a26d112711cf5744b174ba5f39cfb8bccdca8887ab911.png | complex | <table><tr><td></td><td colspan="3">Intention to quit</td><td colspan="3">Quitting smoking</td></tr><tr><td></td><td>OR</td><td colspan="2">95 % CI</td><td>OR</td><td colspan="2">95 % CI</td></tr><tr><td>Province (Hanoi vs Nam Dinh)</td><td>0.47***</td><td>0.34</td><td>0.67</td><td>0.50*</td><td>0.23</td><td>1.08</td><... | <table><tr><td></td><td colspan="2">Intention to quit</td></tr><tr><td></td><td>OR</td><td>95 % CI</td></tr><tr><td>Province (Hanoi vs Nam Dinh)</td><td>0.47***</td><td>0.34</td></tr><tr><td>Location (Urban vs Rural)</td><td>1.44</td><td>0.90</td></tr><tr><td>Duration of MMT (month)</td><td>1.00</td><td>0.99</td></tr><... | <table><tr><td>Intention to quit</td><td colspan="3">Quitting smoking</td></tr><tr><td>95 % CI</td><td>OR</td><td colspan="2">95 % CI</td></tr><tr><td>0.67</td><td>0.50*</td><td>0.23</td><td>1.08</td></tr><tr><td>2.31</td><td></td><td></td><td></td></tr><tr><td>1.02</td><td>0.99</td><td>0.95</td><td>1.03</td></tr><tr><... |
4e19943723e66435374116b3924d16a138f2b8e3311b1df428249869334f7607.png | complex | <table><tr><td></td><td>Testosterone group<i>n</i> = 49</td><td>Placebo group<i>n</i> = 51</td><td>Difference between groups<sup>a</sup></td><td><i>P</i> value<sup>b</sup></td></tr><tr><td colspan="5">Fat mass, kg</td></tr><tr><td> Week 0–10</td><td>–7.9 (–9.7 to –6.1)<sup>*</sup></td><td>–... | <table><tr><td></td></tr><tr><td>Fat mass, kg</td></tr><tr><td>Week 0–10</td></tr><tr><td>Week 0–56</td></tr><tr><td>Fat mass, %</td></tr><tr><td>Week 0–10</td></tr><tr><td>Week 0–56</td></tr><tr><td>Lean mass, kg</td></tr><tr><td>Week 0–10</td></tr><tr><td>Week 0–56</td></tr><tr><td>VAT area, mm2</td></tr><tr><td>Week... | <table><tr><td>Testosterone groupn = 49</td><td>Placebo groupn = 51</td><td>Difference between groupsa</td><td>P valueb</td></tr><tr><td colspan="4">Fat mass, kg</td></tr><tr><td>–7.9 (–9.7 to –6.1)*</td><td>–7.5 (–9.4 to –5.7)*</td><td>–0.4 (–3.0 to 2.2)</td><td>0.78</td></tr><tr><td>–9.4 (–11.3 to –7.5)*</td><td>–6.5... |
4dfa9f4753e42a969a82bae9118658f041fba90e95dbe7eb7232e4999e30ccba.png | simple | <table><tr><td>Documentation practice</td><td>Description</td><td>Number of sites</td></tr><tr><td>Paper-based documentation</td><td>Documentation on a structured paper-based template and later scanned into the EHR in pdf format. No entries of vital signs were done in the EHR.</td><td>2 Sites</td></tr><tr><td>Mixed Doc... | <table><tr><td>Documentation practice</td><td>Description</td><td>Number of sites</td></tr><tr><td>Paper-based documentation</td><td>Documentation on a structured paper-based template and later scanned into the EHR in pdf format. No entries of vital signs were done in the EHR.</td><td>2 Sites</td></tr><tr><td>Mixed Doc... | <table><tr><td>Documentation practice</td><td>Description</td><td>Number of sites</td></tr><tr><td>Digital documentation</td><td>Documentation on a digital template</td><td>4 sites</td></tr></table> |
73aac7b18e3638f660fc21ebe82b9bc9593fdb6b628573da2ebec1b026ba711c.png | complex | <table><tr><td colspan="2">Variable</td><td>Number</td><td>% of total</td><td>% male</td><td>% female</td></tr><tr><td colspan="2">Patients</td><td>64,179</td><td>100.0</td><td>63.6</td><td>36.4</td></tr><tr><td>Age (year)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>≤21</td><td>59,928</... | <table><tr><td colspan="2">Variable</td><td>Number</td><td>% of total</td><td>% male</td><td>% female</td></tr><tr><td colspan="2">Patients</td><td>64,179</td><td>100.0</td><td>63.6</td><td>36.4</td></tr><tr><td>Age (year)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>≤21</td><td>59,928</td><td... | <table><tr><td colspan="2">Variable</td><td>Number</td><td>% of total</td><td>% male</td><td>% female</td></tr><tr><td></td><td>Unknown</td><td>5,595</td><td>8.7</td><td>8.6</td><td>9.0</td></tr><tr><td>Country of birth</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Israel</td><td>50,726</td><td... |
a3c572b4674f081a54ebd99f453e06fedd17987728cdcc3ed89b86d843964ba9.png | simple | <table><tr><td>Study</td><td>Patients (#)</td><td>SRS median total dose/fx</td><td>Follow-up median, range (months)</td><td>Tumor size median, range (cc)</td><td>Prior irradiation Dose, median, range (Gy)</td><td>Toxicity</td><td>Complete Response Rate</td><td>Overall survival</td></tr><tr><td>Voynov et al. [13]</td><t... | <table><tr><td>Study</td><td>Patients (#)</td><td>SRS median total dose/fx</td><td>Follow-up median, range (months)</td><td>Tumor size median, range (cc)</td><td>Prior irradiation Dose, median, range (Gy)</td><td>Toxicity</td><td>Complete Response Rate</td><td>Overall survival</td></tr><tr><td>Voynov et al. [13]</td><t... | <table><tr><td>Study</td><td>Patients (#)</td><td>SRS median total dose/fx</td><td>Follow-up median, range (months)</td><td>Tumor size median, range (cc)</td><td>Prior irradiation Dose, median, range (Gy)</td><td>Toxicity</td><td>Complete Response Rate</td><td>Overall survival</td></tr><tr><td>Heron et al. [15]</td><td... |
42a6f8101b0b70bd48be4f1f6a32743bf7f0428fb0e635dd39c00bae1f5d0a06.png | complex | <table><tr><td>Country</td><td colspan="4">Natural forest cover (1000 ha)</td><td>Loss (1000 ha)</td><td>Coverage %</td><td colspan="3">Annual deforestation rate (%)</td></tr><tr><td></td><td>1990</td><td>2000</td><td>2005</td><td>2010</td><td>1990–2010</td><td>2000</td><td>1990–2000</td><td>2000–2005... | <table><tr><td>Country</td><td colspan="4">Natural forest cover (1000 ha)</td><td>Loss (1000 ha)</td><td>Coverage %</td><td colspan="3">Annual deforestation rate (%)</td></tr><tr><td></td><td>1990</td><td>2000</td><td>2005</td><td>2010</td><td>1990–2010</td><td>2000</td><td>1990–2000</td><td>2000–2005</td><td>2005–2010... | <table><tr><td>Madagascar</td><td>13,461</td><td>12,850</td><td>12,548</td><td>12,138</td><td>1323</td><td>20.2</td><td>−0.5</td><td>−0.45</td><td>−0.55</td></tr><tr><td>Rwanda</td><td>70</td><td>62</td><td>62</td><td>62</td><td>8</td><td>n.a</td><td>−1.1</td><td>−1.14</td><td>0</td></tr><tr><td>Tanzania</td><td>41,345... |
020861e318cb3a3f74f1645a8a5eaac5087e4407f55925e49b98c64d842dc897.png | complex | <table><tr><td>HospitalVolume</td><td>No. ofhospitals inJapan</td><td>No. of beds in Japan (Ni)</td><td colspan="2">No. of beds in DPCparticipating hospitals (ni)</td><td colspan="2">No. of intussusceptionfrom July to December(Xi)</td><td colspan="2">Estimated No. of cases per year(Yi)</td></tr><tr><td></td><td></td><t... | <table><tr><td>HospitalVolume</td><td>No. ofhospitals inJapan</td><td>No. of beds in Japan (Ni)</td><td colspan="2">No. of beds in DPCparticipating hospitals (ni)</td><td colspan="2">No. of intussusceptionfrom July to December(Xi)</td><td colspan="2">Estimated No. of cases per year(Yi)</td></tr><tr><td></td><td></td><t... | <table><tr><td>HospitalVolume</td><td>No. ofhospitals inJapan</td><td>No. of beds in Japan (Ni)</td><td colspan="2">No. of beds in DPCparticipating hospitals (ni)</td><td colspan="2">No. of intussusceptionfrom July to December(Xi)</td><td colspan="2">Estimated No. of cases per year(Yi)</td></tr><tr><td>Total</td><td>7,... |
31602009a94fbe6a6da192a52004c646f874b2129f6e75c9e49b82811765734f.png | simple | <table><tr><td>Markers</td><td>Afreq</td><td>Families</td><td>S</td><td>E(s)</td><td>Z</td><td><i>p</i>-values</td></tr><tr><td>rs4366301</td><td>C:0.831G:0.169</td><td>169169</td><td>213.00125.00</td><td>233.00105.00</td><td>-2.8722.872</td><td>0.0040.004</td></tr><tr><td>rs11585959</td><td>C:0.243T:0.757</td><td>2162... | <table><tr><td>Markers</td><td>Afreq</td><td>Families</td><td>S</td><td>E(s)</td><td>Z</td><td>p-values</td></tr><tr><td>rs4366301</td><td>C:0.831G:0.169</td><td>169169</td><td>213.00125.00</td><td>233.00105.00</td><td>-2.8722.872</td><td>0.0040.004</td></tr><tr><td>rs11585959</td><td>C:0.243T:0.757</td><td>216216</td>... | <table><tr><td>Markers</td><td>Afreq</td><td>Families</td><td>S</td><td>E(s)</td><td>Z</td><td>p-values</td></tr><tr><td>rs6668845</td><td>G:0.332A:0.668</td><td>244244</td><td>172.00316.00</td><td>193.00295.00</td><td>-2.3262.326</td><td>0.0200.020</td></tr><tr><td>rs10864698</td><td>A:0.330G:0.670</td><td>242242</td>... |
a0b13115f57b00a3e00bea79e50c7d49c6954536c0c9cf2301795fffa5948a65.png | complex | <table><tr><td rowspan="2" colspan="2">Materials</td><td colspan="3">Melting</td><td colspan="3">Solidification</td></tr><tr><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td></tr><tr>... | <table><tr><td rowspan="2" colspan="2">Materials</td><td colspan="3">Melting</td><td colspan="3">Solidification</td></tr><tr><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td></tr><tr><td rowspan="3">FS T... | <table><tr><td rowspan="2" colspan="2">Materials</td><td colspan="3">Melting</td><td colspan="3">Solidification</td></tr><tr><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td></tr><tr><td rowspan="3">FS T... |
b79bfe75e8ad323e72143070cec4596c598aaf4ddefb4ab352f1045a5aefe1d5.png | complex | <table><tr><td>Variable</td><td></td><td>Totaln (%)</td><td>Normaln (%)</td><td>Anemia<sup>1</sup>n (%)</td><td>X<sup>2</sup></td><td>P</td></tr><tr><td colspan="7">Occupation</td></tr><tr><td></td><td>Mixed farming</td><td>351 (36.2)</td><td>266 (75.8)</td><td>85 (24.2)</td><td>21.7</td><td>0.001</td></tr><tr><td></td... | <table><tr><td>Variable</td><td></td><td>Totaln (%)</td><td>Normaln (%)</td><td>Anemia1n (%)</td><td>X2</td><td>P</td></tr><tr><td colspan="7">Occupation</td></tr><tr><td></td><td>Mixed farming</td><td>351 (36.2)</td><td>266 (75.8)</td><td>85 (24.2)</td><td>21.7</td><td>0.001</td></tr><tr><td></td><td>Livestock</td><td... | <table><tr><td>Variable</td><td></td><td>Totaln (%)</td><td>Normaln (%)</td><td>Anemia1n (%)</td><td>X2</td><td>P</td></tr><tr><td></td><td>Less than once a day</td><td>403 (41.5)</td><td>274 (68.0)</td><td>129 (32.0)</td><td></td><td></td></tr><tr><td colspan="7">Meat consumption weekly</td></tr><tr><td></td><td>Once ... |
dbeb82d9be4fbd1c65299092132015d62250b8222e09775c870860da27cc429c.png | simple | <table><tr><td> </td><td> Total</td><td> Woman</td><td> Man</td></tr><tr><td>Total thyroidectomy</td><td> 166</td><td> 125 (75.3)<sup><i>∗</i></sup></td><td> 41 (24.7)</td></tr><tr><td>Pyramidal lobe present</td><td> 109 (65.7)</td><td> 82 (65.6)</td><td> 27 (65.9) </td></tr><tr><td>Pyramidal lobe absent</td><td>... | <table><tr><td></td><td>Total</td><td>Woman</td><td>Man</td></tr></table> | <table><tr><td>Total thyroidectomy</td><td>166</td><td>125 (75.3)∗</td><td>41 (24.7)</td></tr><tr><td>Pyramidal lobe present</td><td>109 (65.7)</td><td>82 (65.6)</td><td>27 (65.9)</td></tr><tr><td>Pyramidal lobe absent</td><td>57 (34.3)</td><td>43 (34.4)</td><td>14 (34.1)</td></tr></table> |
676a831aec721d1e6d1e4c39b388fd3790787506e0f5a21d2cc3d3ae13c5ea54.png | simple | <table><tr><td>Parameters</td><td>Control group</td><td>500 mg/kg·b·wt (A)</td><td>1000 mg/kg·b·wt (B)</td><td>2000 mg/kg·b·wt (C)</td></tr><tr><td>Number of examined fetuses</td><td>15</td><td>15</td><td>15</td><td>15</td></tr><tr><td>Impairment of skull ossification</td><td>—</td><... | <table><tr><td>Parameters</td><td>Control group</td><td>500 mg/kg·b·wt (A)</td><td>1000 mg/kg·b·wt (B)</td><td>2000 mg/kg·b·wt (C)</td></tr><tr><td>Number of examined fetuses</td><td>15</td><td>15</td><td>15</td><td>15</td></tr><tr><td>Impairment of skull ossification</td><td>—</td><td>3 (20%)</td><td>5 (33.33%)</td><t... | <table><tr><td>Parameters</td><td>Control group</td><td>500 mg/kg·b·wt (A)</td><td>1000 mg/kg·b·wt (B)</td><td>2000 mg/kg·b·wt (C)</td></tr><tr><td>Absence or dislocation of sternebrae</td><td>—</td><td>2 (13.33%)</td><td>3 (20%)</td><td>5 (33.33%)</td></tr><tr><td>Reduction or absence of caudal vertebrae</td><td>—</td... |
cb5dc6d443444bd3d960ebd5b6c4011cd697ad7d5c4073f94f46f1c383121354.png | complex | <table><tr><td>Criteria</td><td>Total n</td><td>Normosmic</td><td>Hyposmic</td><td>Anosmic</td></tr><tr><td colspan="5">TOAST criteria</td></tr><tr><td> Large artery atherosclerosis</td><td>11</td><td>7</td><td>2</td><td>2</td></tr><tr><td> Cardioembolism</td><td>21</td><td>14</td><td>4</td><td>3</td></tr><tr><td> Smal... | <table><tr><td>Criteria</td><td>Total n</td><td>Normosmic</td><td>Hyposmic</td><td>Anosmic</td></tr><tr><td colspan="5">TOAST criteria</td></tr><tr><td>Large artery atherosclerosis</td><td>11</td><td>7</td><td>2</td><td>2</td></tr><tr><td>Cardioembolism</td><td>21</td><td>14</td><td>4</td><td>3</td></tr><tr><td>Small v... | <table><tr><td>PACI</td><td>37</td><td>18</td><td>11</td><td>8</td></tr><tr><td>POCI</td><td>12</td><td>9</td><td>2</td><td>1</td></tr><tr><td>TACI</td><td>4</td><td>2</td><td>1</td><td>1</td></tr><tr><td>LACI</td><td>20</td><td>11</td><td>7</td><td>2</td></tr></table> |
d2d91ed4c86d63a558badf530cd792e550027991804b8716fc810a4f1c45253b.png | simple | <table><tr><td>Variable</td><td>Response</td><td>Surgeon 1</td><td>Surgeon 2</td><td><i>P</i></td></tr><tr><td>Operative time, no previous abdominal surgery</td><td>N, Mean ± SD</td><td>59, 45.6 ± 12.9</td><td>13, 73.2 ± 13.6</td><td>< 0.001</td></tr><tr><td>Operative time, previous abdominal surgery<... | <table><tr><td>Variable</td><td>Response</td><td>Surgeon 1</td><td>Surgeon 2</td><td>P</td></tr><tr><td>Operative time, no previous abdominal surgery</td><td>N, Mean ± SD</td><td>59, 45.6 ± 12.9</td><td>13, 73.2 ± 13.6</td><td>< 0.001</td></tr></table> | <table><tr><td>Variable</td><td>Response</td><td>Surgeon 1</td><td>Surgeon 2</td><td>P</td></tr><tr><td>Operative time, previous abdominal surgery</td><td>N, Mean ± SD</td><td>43, 44.0 ± 12.6</td><td>2, 115.5 ± 2.1</td><td>0.019</td></tr></table> |
98640e52e090d892e77b5ac3f1f336a7cec1001c1afe08e72bfcf2e2b5529181.png | simple | <table><tr><td>Region</td><td>Control</td><td>Autism</td><td><i>t</i>-value</td><td><i>P</i></td></tr><tr><td>Amygdala</td><td>3.93 ± 0.64</td><td>3.69 ± 0.57</td><td>0.58</td><td>0.58</td></tr><tr><td>Caudate nucleus</td><td>4.28 ± 0.47</td><td>4.56 ± 0.62</td><td>0.67</td><td>0.52</td></tr><tr><td... | <table><tr><td>Region</td><td>Control</td><td>Autism</td><td>t-value</td><td>P</td></tr><tr><td>Amygdala</td><td>3.93 ± 0.64</td><td>3.69 ± 0.57</td><td>0.58</td><td>0.58</td></tr><tr><td>Caudate nucleus</td><td>4.28 ± 0.47</td><td>4.56 ± 0.62</td><td>0.67</td><td>0.52</td></tr><tr><td>Cerebellum</td><td>1.07 ± 0.10</t... | <table><tr><td>Region</td><td>Control</td><td>Autism</td><td>t-value</td><td>P</td></tr><tr><td>Paracentral gyrus</td><td>2.89 ± 0.44</td><td>3.36 ± 0.32</td><td>1.83</td><td>0.11</td></tr><tr><td>Parahippocampus</td><td>3.25 ± 0.09</td><td>3.55 ± 0.40</td><td>1.22</td><td>0.26</td></tr><tr><td>Parietal lobe</td><td>3.... |
f8c88fa8479096b9a4fa453ed0cb63bf69075cf0b29728d3889dbd9c11efba23.png | simple | <table><tr><td></td><td>"0" + EC</td><td>"0" + NEC</td><td>p</td></tr><tr><td>Number of cycles</td><td>50</td><td>39</td><td></td></tr><tr><td>Maternal age (mean ± SD)</td><td>30.3 ± 4.0</td><td>31.6 ± 3.4</td><td>>0.5</td></tr><tr><td>Total number of embryos transferred</td><td>75</td><td>75</td><td>... | <table><tr><td></td><td>"0" + EC</td><td>"0" + NEC</td><td>p</td></tr><tr><td>Number of cycles</td><td>50</td><td>39</td><td></td></tr><tr><td>Maternal age (mean ± SD)</td><td>30.3 ± 4.0</td><td>31.6 ± 3.4</td><td>>0.5</td></tr><tr><td>Total number of embryos transferred</td><td>75</td><td>75</td><td></td></tr><tr><td>... | <table><tr><td>IR (%)</td><td>43</td><td>27</td><td>0.038</td></tr></table> |
4360b4c4224ac2a0b6ba675753c82c55f70be1f82c1d4f0cd7d89813c0054533.png | complex | <table><tr><td></td><td colspan="2">Current study</td><td colspan="3">Previous studies</td></tr><tr><td>SSC<sup>a</sup></td><td>Position 1</td><td>Position 2</td><td>Position 1</td><td>Position 2</td><td>Trait</td></tr><tr><td>1</td><td>181,896,016</td><td>186,896,016</td><td>105,873,529</td><td>290,457,491</td><td>tea... | <table><tr><td></td><td colspan="2">Current study</td><td colspan="3">Previous studies</td></tr><tr><td>SSCa</td><td>Position 1</td><td>Position 2</td><td>Position 1</td><td>Position 2</td><td>Trait</td></tr><tr><td>1</td><td>181,896,016</td><td>186,896,016</td><td>105,873,529</td><td>290,457,491</td><td>teat number [3... | <table><tr><td></td><td colspan="2">Current study</td><td colspan="3">Previous studies</td></tr><tr><td>SSCa</td><td>Position 1</td><td>Position 2</td><td>Position 1</td><td>Position 2</td><td>Trait</td></tr><tr><td>7</td><td></td><td>743,041</td><td>8,014,191</td><td>81</td><td>teum number [38]</td></tr><tr><td></td><... |
cce4ef163f54add645b48ae30d8ead05483e6c2f452fc94e8745c15aea378bdc.png | complex | <table><tr><td rowspan="3">Organs</td><td colspan="6">%ID/g</td></tr><tr><td colspan="2">4 h</td><td colspan="2">24 h</td><td colspan="2">120 h</td></tr><tr><td><sup>131</sup>I-prohy</td><td>CA4P + <sup>131</sup>I-prohy</td><td><sup>131</sup>I-prohy</td><td>CA4P + <sup>131</sup>I-prohy</td><td><sup>131</sup>I-prohy</td... | <table><tr><td rowspan="3">Organs</td><td colspan="2">%ID/g</td></tr><tr><td colspan="2">4 h</td></tr><tr><td>131I-prohy</td><td>CA4P + 131I-prohy</td></tr><tr><td>Blood</td><td>4.43 ± 0.14</td><td>4.75 ± 0.65</td></tr><tr><td>Thyroid</td><td>0.47 ± 0.03</td><td>1.14 ± 0.07**</td></tr><tr><td>Lung</td><td>2.71 ± 0.23</... | <table><tr><td colspan="4">%ID/g</td></tr><tr><td colspan="2">24 h</td><td colspan="2">120 h</td></tr><tr><td>131I-prohy</td><td>CA4P + 131I-prohy</td><td>131I-prohy</td><td>CA4P + 131I-prohy</td></tr><tr><td>0.66 ± 0.08</td><td>0.74 ± 0.03</td><td>0.06 ± 0.01</td><td>0.09 ± 0.02*</td></tr><tr><td>0.08 ± 0.02</td><td>0... |
20fb804cd52141adc4677d153e084051659fb73a412344cd642e8a46ee094878.png | simple | <table><tr><td>Age, sex</td><td>NOAC</td><td>Lesion</td><td>Prescription (month)</td><td>BARC</td><td>Other factors</td></tr><tr><td>Upper GI</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 92 F</td><td>D</td><td>Gastric ulcer</td><td>11</td><td>3a</td><td>PPI (-)</td></tr><tr><td> 96 F</td><td>R</t... | <table><tr><td>Age, sex</td><td>NOAC</td><td>Lesion</td><td>Prescription (month)</td><td>BARC</td><td>Other factors</td></tr><tr><td>Upper GI</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>92 F</td><td>D</td><td>Gastric ulcer</td><td>11</td><td>3a</td><td>PPI (-)</td></tr><tr><td>96 F</td><td>R</td><td>G... | <table><tr><td>Age, sex</td><td>NOAC</td><td>Lesion</td><td>Prescription (month)</td><td>BARC</td><td>Other factors</td></tr><tr><td>72 M</td><td>A</td><td>Duodenal ulcer</td><td>25</td><td>3b</td><td>PPI (-), operation</td></tr><tr><td>Lower GI</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>78 M</td><td... |
2ea537b487632c73364b4b66951e4168fe5531d8ffc90f7d9a64d5b5de24002f.png | simple | <table><tr><td>Parameter or measurement</td><td>July</td><td>Aug</td><td>Sept</td><td>Oct</td><td>Nov</td><td>Dec</td></tr><tr><td>OPD attendances</td><td>14,940</td><td>15,354</td><td>10,927</td><td>13,265</td><td>9,561</td><td>10,737</td></tr><tr><td>Presumed malaria</td><td>8,041</td><td>7,733</td><td>5,844</td><td>... | <table><tr><td>Parameter or measurement</td><td>July</td><td>Aug</td><td>Sept</td><td>Oct</td><td>Nov</td><td>Dec</td></tr><tr><td>OPD attendances</td><td>14,940</td><td>15,354</td><td>10,927</td><td>13,265</td><td>9,561</td><td>10,737</td></tr><tr><td>Presumed malaria</td><td>8,041</td><td>7,733</td><td>5,844</td><td>... | <table><tr><td>Parameter or measurement</td><td>July</td><td>Aug</td><td>Sept</td><td>Oct</td><td>Nov</td><td>Dec</td></tr><tr><td>*</td><td>)</td><td>%)</td><td>0%)</td><td></td><td></td><td>%)</td></tr><tr><td>Anti-malaria prescriptions</td><td>5,143</td><td>5,550</td><td>3,815</td><td>4121</td><td>3,486</td><td>3,81... |
951052605b29a77e7b49bd93cbc7d7a9dcfb5ef2aae5ee27dae403fee232c2a0.png | simple | <table><tr><td>Order</td><td>Reading</td><td>Location (<i>x</i>, <i>y</i>)</td></tr><tr><td>1</td><td>1</td><td>(1.5, 3.0)</td></tr><tr><td>2</td><td>4</td><td>(3.0, 3.3)</td></tr><tr><td>3</td><td>4</td><td>(2.8, 1.9)</td></tr><tr><td>4</td><td>5</td><td>(2.3, 0.9)</td></tr><tr><td>5</td><td>3</td><td>(4.3, 0.4)</td><... | <table><tr><td>Order</td><td>Reading</td><td>Location (x, y)</td></tr><tr><td>1</td><td>1</td><td>(1.5, 3.0)</td></tr><tr><td>2</td><td>4</td><td>(3.0, 3.3)</td></tr><tr><td>3</td><td>4</td><td>(2.8, 1.9)</td></tr><tr><td>4</td><td>5</td><td>(2.3, 0.9)</td></tr></table> | <table><tr><td>Order</td><td>Reading</td><td>Location (x, y)</td></tr><tr><td>5</td><td>3</td><td>(4.3, 0.4)</td></tr><tr><td>6</td><td>5</td><td>(5.8, 1.3)</td></tr><tr><td>7</td><td>6</td><td>(5.4, 2.9)</td></tr><tr><td>8</td><td>7</td><td>(4.3, 4.0)</td></tr><tr><td>9</td><td>3</td><td>(2.2, 4.4)</td></tr><tr><td>10... |
6ba67dac4661284b0adefd1a2f5888f3a7695f12b333cdceb839319794957fcf.png | complex | <table><tr><td> </td><td colspan="2">CMM</td><td colspan="2">SCC</td></tr><tr><td> </td><td>Events/Pyr<sup>1</sup></td><td>OR (95% CI)</td><td>Events/Pyr</td><td>OR (95% CI)</td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Female</td><td>2058/173 679</td><td>1.00 ref</td><td>1893/81 108</t... | <table><tr><td></td><td colspan="2"></td><td colspan="2">S</td></tr></table> | <table><tr><td></td><td colspan="2">CMM</td><td colspan="2">CC</td></tr><tr><td></td><td>Events/Pyr1</td><td>OR (95% CI)</td><td>Events/Pyr</td><td>OR (95% CI)</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td>Female</td><td>2058/173 679</td><td>1.00 ref</td><td>1893/81 108</td><td>1.00 ref</td>... |
377241992d1c23fb657313e76ba94ab6e8e0786a42fd34ee475b27bdf90571c2.png | simple | <table><tr><td>New</td><td></td><td></td><td></td><td></td></tr><tr><td>Risk Factor</td><td></td><td>Adjusted Odds Ratio</td><td>95% Confidence Interval</td><td>P-value</td></tr><tr><td>Any family member suffering from hepatitis B & C</td><td>Yes</td><td>14.5</td><td>9.5-22.1</td><td>0.001</td></tr><tr><td></td><td... | <table><tr><td>New</td><td></td><td></td><td></td><td></td></tr><tr><td>Risk Factor</td><td></td><td>Adjusted Odds Ratio</td><td>95% Confidence Interval</td><td>P-value</td></tr><tr><td>Any family member suffering from hepatitis B & C</td><td>Yes</td><td>14.5</td><td>9.5-22.1</td><td>0.001</td></tr><tr><td></td><td>No<... | <table><tr><td>New</td><td></td><td></td><td></td><td></td></tr><tr><td>Blood transfusion</td><td>Yes</td><td>2.9</td><td>1.2-7.3</td><td>0.017</td></tr><tr><td></td><td>No</td><td>Reference</td><td></td><td></td></tr><tr><td>History of IV/IM injection/year</td><td>None</td><td>Reference</td><td></td><td></td></tr><tr>... |
79e4858f0b00e0499bac7b357a970266641635c5245049504c9dd6fa3e07ff1e.png | simple | <table><tr><td>Case</td><td>Age</td><td>Gender</td><td>HSCT source</td><td>Underlying disease</td><td>Interval between HSCT and CM analysis (mo)</td><td>Interval between DE onset and CM analysis (mo)</td><td>Interval between HSCT and DE onset (mo)</td><td>DE severity level</td><td>CC</td><td>Clinically affected cGVHD o... | <table><tr><td>Case</td><td>Age</td><td>Gender</td><td>HSCT source</td><td>Underlying disease</td><td>Interval between HSCT and CM analysis (mo)</td><td>Interval between DE onset and CM analysis (mo)</td><td>Interval between HSCT and DE onset (mo)</td><td>DE severity level</td><td>CC</td><td>Clinically affected cGVHD o... | <table><tr><td></td><td></td><td>Female</td><td></td><td>L</td><td>2</td><td></td><td>2</td><td>2</td><td></td><td></td></tr><tr><td>6</td><td>57</td><td>Male</td><td>BM</td><td>MDS</td><td>14</td><td>N.A.</td><td>N.A.</td><td>3</td><td>+</td><td>Eye</td></tr><tr><td>7</td><td>51</td><td>Male</td><td>BM</td><td>CML</td... |
51d1e0351be2b5104afca18b15c8596021e1554ee6a7267fa8cd0923c360e8b5.png | simple | <table><tr><td>SNP rsID</td><td>Marker name</td><td>Amino acid change</td><td>Chromosome</td><td>Cytoband</td><td><i>P</i>-values</td></tr><tr><td>rs4149015</td><td>SLCO1B1 c.-11187G > A</td><td>Promoter</td><td>12</td><td>p12.2</td><td>0.0001</td></tr><tr><td>rs1060253</td><td>SLC7A5 c.<sup>∗</sup>438C > G... | <table><tr><td>SNP rsID</td><td>Marker name</td><td>Amino acid change</td><td>Chromosome</td><td>Cytoband</td><td>P-values</td></tr><tr><td>rs4149015</td><td>SLCO1B1 c.-11187G > A</td><td>Promoter</td><td>12</td><td>p12.2</td><td>0.0001</td></tr><tr><td>rs1060253</td><td>SLC7A5 c.∗438C > G</td><td>3′UTR</td><td>16</td>... | <table><tr><td>SNP rsID</td><td>Marker name</td><td>Amino acid change</td><td>Chromosome</td><td>Cytoband</td><td>P-values</td></tr><tr><td>rs4149117</td><td>SLCO1B3 c.334G > T</td><td>A112S</td><td>12</td><td>p12.2</td><td>0.0021</td></tr><tr><td>rs7311358</td><td>SLCO1B3 c.699A > G</td><td>I233M</td><td>12</td><td>p1... |
ca415ee9abc9f6340d1d9afb67109ffcc68c1affa286b1507528239d651ff769.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">Active partitions MIC values (<i>μ</i>g/ml)</td><td colspan="3">Reference antibioticsMIC values (<i>μ</i>g/ml)</td></tr><tr><td>CSBt</td><td>CSEA</td><td>Amox</td><td>Gent</td><td>Vanc</td></tr><tr><td>Gram – bacteria</td><td> </td><td> </td><td> </td><td... | <table><tr><td rowspan="2"></td><td colspan="2">Active partitions MIC values (μg/ml)</td><td colspan="2">Reference antibioticsMIC values (μg/ml)</td></tr><tr><td>CSBt</td><td>CSEA</td><td>Amox</td><td>Gent</td></tr><tr><td>Gram – bacteria</td><td></td><td></td><td></td><td></td></tr><tr><td>Escherichia coli T20A2</td><... | <table><tr><td>Reference antibioticsMIC values (μg/ml)</td></tr><tr><td>Vanc</td></tr><tr><td></td></tr><tr><td>R</td></tr><tr><td>R</td></tr><tr><td>R</td></tr><tr><td></td></tr><tr><td>S</td></tr><tr><td>S</td></tr><tr><td>S</td></tr><tr><td>S</td></tr><tr><td>S</td></tr><tr><td>S</td></tr><tr><td>R</td></tr><tr><td>... |
3b8b63fead91e5cba52ea7ed0e1c96a19b17974c25883f8d86772e4e6836e241.png | complex | <table><tr><td rowspan="3">Credit Points(Score)</td><td rowspan="3">Class</td><td colspan="2">Premium Reduction</td><td rowspan="3">Number of LouisianaParishes</td></tr><tr><td>(SFHA)</td><td>Non-SFHA</td></tr><tr><td>4500+</td><td>1</td><td>45%</td><td>10%</td><td>0</td></tr><tr><td>4000–4499</td><td>2</td><td>4... | <table><tr><td rowspan="3">Credit Points(Score)</td><td rowspan="3">Class</td><td colspan="2">Premium Reduction</td><td rowspan="3">Number of LouisianaParishes</td></tr><tr><td>(SFHA)</td><td>Non-SFHA</td></tr><tr><td colspan="2"></td></tr></table> | <table><tr><td>4500+</td><td>1</td><td>45%</td><td>10%</td><td>0</td></tr><tr><td>4000–4499</td><td>2</td><td>40%</td><td>10%</td><td>0</td></tr><tr><td>3500–3999</td><td>3</td><td>35%</td><td>10%</td><td>0</td></tr><tr><td>3000–3499</td><td>4</td><td>30%</td><td>10%</td><td>0</td></tr><tr><td>2500–2999</td><td>5</td><... |
b8c9a9fd0500534e5754d5d974aa195188c564e22b37a9ee4e0abc67bcdd7ff4.png | complex | <table><tr><td></td><td colspan="2">Rest</td><td colspan="2">ΔActive standing</td><td colspan="2">ΔHandgrip</td></tr><tr><td></td><td>T1D</td><td>CON</td><td>T1D</td><td>CON</td><td>T1D</td><td>CON</td></tr><tr><td>Heart rate (bpm)</td><td>59 (12)</td><td>58 (16)</td><td>+20* (13)</td><td>+26* (16)</td><td>+2... | <table><tr><td></td><td colspan="2">Rest</td><td colspan="2">ΔActive standing</td><td colspan="2">ΔHandgrip</td></tr><tr><td></td><td>T1D</td><td>CON</td><td>T1D</td><td>CON</td><td>T1D</td><td>CON</td></tr><tr><td>Heart rate (bpm)</td><td>59 (12)</td><td>58 (16)</td><td>+20* (13)</td><td>+26* (16)</td><td>+22* (16)‡</... | <table><tr><td>Diastolic (mmHg)</td><td>66 (8)</td><td>65 (7)</td><td>+11* (9)</td><td>+7.6* (12)</td><td>+26* (16)§</td><td>+29* (9)</td></tr></table> |
18a1c7ca6bf0124d80b32b1f85155eb2a209e0e85651d8506d644068b51b8ddd.png | complex | <table><tr><td> </td><td colspan="4">Species</td></tr><tr><td>Habitat characteristics</td><td><i>An. arabiensis</i></td><td><i>An. chrysti</i></td><td><i>An. cinereus</i></td><td><i>An. demeilloni</i></td></tr><tr><td>Correlation</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>pH</td><td>−0.2</td><td>0.0... | <table><tr><td></td><td colspan="4">Species</td></tr><tr><td>Habitat characteristics</td><td>An. arabiensis</td><td>An. chrysti</td><td>An. cinereus</td><td>An. demeilloni</td></tr><tr><td>Correlation</td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>pH</td><td>−0.2</td><td>0.0</td><td>0.1</td><td>−0.2</td></tr><tr><td>Temperature (0 C)</td><td>0.3*</td><td>−0.1</td><td>0.2</td><td>−0.3*</td></tr><tr><td>Depth (cm)</td><td>−0.6**</td><td>0.2</td><td>0.0</td><td>0.2</td></tr><tr><td>Differences of means (medians)</td><td></td><td></td><td></td><td></t... |
dde9b79902f36c4d5dc2bd970b95ed49792142bbb4a379f30e3e627f683e3da6.png | simple | <table><tr><td>Metals</td><td>Cu</td><td>Zn</td><td>As</td><td>Hg</td><td>Pb</td><td>Cd</td><td>Cr</td></tr><tr><td>Cu</td><td>1</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Zn</td><td>–0.256</td><td>1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>As</td><td>0.194</td><td... | <table><tr><td>Metals</td><td>Cu</td><td>Zn</td><td>As</td><td>Hg</td><td>Pb</td></tr><tr><td>Cu</td><td>1</td><td></td><td></td><td></td><td></td></tr><tr><td>Zn</td><td>–0.256</td><td>1</td><td></td><td></td><td></td></tr><tr><td>As</td><td>0.194</td><td>0.467**</td><td>1</td><td></td><td></td></tr><tr><td>Hg</td><td... | <table><tr><td>Cd</td><td>Cr</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td>1</td><td></td></tr><tr><td>–0.066</td><td>1</td></tr></table> |
5a22fc09115f33cb6458106338199e24f65c6a9c2c0c9ff4c398e04344668c7e.png | complex | <table><tr><td>SNV</td><td>bp</td><td>Conserved Region<i><sup>a</sup></i></td><td><i>P</i>-Value<i><sup>b</sup></i></td><td>Alleles<i><sup>c</sup></i></td><td>MAF<i><sup>d</sup></i></td><td colspan="3">Unaffected</td><td colspan="3">Scoliosis</td><td colspan="4">Kyphoscoliosis</td></tr><tr><td>rs114080324</td><td>29474... | <table><tr><td>SNV</td><td>bp</td><td>Conserved Regiona</td><td>P-Valueb</td><td>Allelesc</td><td>MAFd</td><td colspan="3">Unaffected</td><td colspan="3">Scoliosis</td><td colspan="4">Kyphoscoliosis</td></tr></table> | <table><tr><td>rs114080324</td><td>2947499</td><td>Yes</td><td>0.116</td><td>G/A</td><td>0.006</td><td>GG</td><td>GG</td><td>GG</td><td>—</td><td>GG</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td></tr><tr><td>rs183225473</td><td>3045672</td><td>No</td><td>0.039</td><td>G/C</td><td>0.006</td><td>GG</td><td>G... |
5982081deb9bcfee76d554ea6195acfbf0c29def190bcf461ece0a0d53ee3a60.png | complex | <table><tr><td>Variables</td><td colspan="2">All</td><td colspan="2">Physicians</td><td colspan="2">Nurses</td></tr><tr><td> </td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Male</td><td>29.5</td><td>156</td... | <table><tr><td>Variables</td><td colspan="2">All</td><td colspan="2">Physicians</td><td colspan="2">Nurses</td></tr><tr><td></td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>29.5</td><td>156</td><td>56... | <table><tr><td>Variables</td><td colspan="2">All</td><td colspan="2">Physicians</td><td colspan="2">Nurses</td></tr><tr><td></td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td></tr><tr><td>≤80</td><td>54.0</td><td>271</td><td>29.2</td><td>52</td><td>67.6</td><td>219</td></tr><tr><td>80 to 160</td><td>33.7<... |
bcb4197fe4425a99e9c8941d5cf83bb75a4cd88238a70f97061b5345a648fe87.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Cases 2002–2008 (<i>N</i> = 1064)</td><td colspan="5">Cases 2013–2015</td><td rowspan="2"><i>P</i></td></tr><tr><td>Total cases <i>N</i> = 990</td><td>Anterior <i>N</i> = 530</td><td>Intermediate <i>N</i> = 74</td><td>Panuveitis <i>N</i> = 226</td><td>... | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Cases 2002–2008 (N = 1064)</td><td colspan="5">Cases 2013–2015</td><td rowspan="2">P</td></tr><tr><td>Total cases N = 990</td><td>Anterior N = 530</td><td>Intermediate N = 74</td><td>Panuveitis N = 226</td><td>Posterior N = 160</td></tr><tr><td>Median age at prese... | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Cases 2002–2008 (N = 1064)</td><td colspan="5">Cases 2013–2015</td><td rowspan="2">P</td></tr><tr><td>Total cases N = 990</td><td>Anterior N = 530</td><td>Intermediate N = 74</td><td>Panuveitis N = 226</td><td>Posterior N = 160</td></tr><tr><td>Unilateral</td><td>... |
e82f8b54121f028ee5c98ab3089f8f86e36888b67b4f3640c9909ea7fa881092.png | simple | <table><tr><td></td><td>Total number of patients(n = 376)</td></tr><tr><td>Trials</td><td></td></tr><tr><td> Ludman [27]</td><td>40 (11%)</td></tr><tr><td> Crimi [28]</td><td>76 (20%)</td></tr><tr><td> Garcia-Dorado [30]</td><td>177 (47%)</td></tr><tr><td> White [29]</td><td>83 (22%)</td></tr><tr><td>Randomization</td>... | <table><tr><td></td><td>Total number of patients(n = 376)</td></tr><tr><td>Trials</td><td></td></tr><tr><td>Ludman [27]</td><td>40 (11%)</td></tr><tr><td>Crimi [28]</td><td>76 (20%)</td></tr><tr><td>Garcia-Dorado [30]</td><td>177 (47%)</td></tr><tr><td>White [29]</td><td>83 (22%)</td></tr><tr><td>Randomization</td><td>... | <table><tr><td></td><td>Total number of patients(n = 376)</td></tr><tr><td>LVESV</td><td>78 ± 31</td></tr><tr><td>LVEF</td><td>50 ± 11</td></tr><tr><td>MI size/%LV</td><td>22 ± 11</td></tr><tr><td>AAR/%LV</td><td>33 ± 12</td></tr><tr><td>MI size/%AAR</td><td>64 ± 21</td></tr><tr><td>MVO/%</td><td>111 (53%)</td></tr></t... |
f2d05dd2e06a7079357cfb26275ee67c9252feda1fb56f00d24dcfa042262efb.png | simple | <table><tr><td>Probe Set ID</td><td>Gene Title</td><td>Gene Symbol</td><td>FC in tumors</td><td>GO biological function</td></tr><tr><td>99104_at</td><td>adiponectin, C1Q and collagen domain containing</td><td>Adipoq</td><td>-21.75</td><td>Lipid metabolism, Organic acid metabolism</td></tr><tr><td>99671_at</td><td>adips... | <table><tr><td>Probe Set ID</td><td>Gene Title</td><td>Gene Symbol</td><td>FC in tumors</td><td>GO biological function</td></tr><tr><td>99104_at</td><td>adiponectin, C1Q and collagen domain containing</td><td>Adipoq</td><td>-21.75</td><td>Lipid metabolism, Organic acid metabolism</td></tr><tr><td>99671_at</td><td>adips... | <table><tr><td>Probe Set ID</td><td>Gene Title</td><td>Gene Symbol</td><td>FC in tumors</td><td>GO biological function</td></tr><tr><td>101539_f_at</td><td>carboxylesterase 3</td><td>Ces3</td><td>-4.06</td><td>Lipid metabolism, Organic acid metabolism</td></tr><tr><td>102016_at</td><td>cell death-inducing DFFA-like eff... |
b6e4c81ea6e03fc587bcb58222ac3a7261d30088eb5439719d564160e518a972.png | complex | <table><tr><td rowspan="2">Studies groups</td><td rowspan="2">No of reports</td><td rowspan="2">Relative risk (95% CI)</td><td colspan="2">Heterogeneity</td><td rowspan="2"><i>P</i> for test</td></tr><tr><td><i>P</i> value</td><td>I<sup>2</sup> (%)</td></tr><tr><td>Total</td><td>22</td><td>0.86 (0.78–0.92)</td><t... | <table><tr><td rowspan="2">Studies groups</td><td rowspan="2">No of reports</td><td rowspan="2">Relative risk (95% CI)</td><td colspan="2">Heterogeneity</td><td rowspan="2">P for test</td></tr><tr><td>P value</td><td>I2 (%)</td></tr><tr><td>Total</td><td>22</td><td>0.86 (0.78–0.92)</td><td>0.001</td><td>54.9%</td><td>0... | <table><tr><td>≥ 1000</td><td>11</td><td>0.83 (0.73–0.94)</td><td>0.162</td><td>24.2%</td><td>0.005</td></tr><tr><td>< 1000</td><td>11</td><td>0.90 (0.81–0.98)</td><td>0.001</td><td>65.8%</td><td>0.013</td></tr><tr><td>Study quality</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Score ≥ 7</td><td>20</td>... |
d3524095a414c8bf66c9861e1e4061971265f68a7942d56cdb754f678778563f.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">STX</td><td colspan="2">Okadaic Acid, DTXS</td><td colspan="2">Domoic Acid</td></tr><tr><td colspan="2">(PSP)</td><td colspan="2">(DSP)</td><td colspan="2">(ASP)</td></tr><tr><td>Sampling Date</td><td>Multi SPR</td><td>ELISA</td><td>Multi SPR</td><td>ELISA</td><td>Multi S... | <table><tr><td></td><td colspan="2">STX</td><td colspan="2">Okadaic Acid, DTXS</td><td colspan="2">Domoic Acid</td></tr></table> | <table><tr><td></td><td colspan="2">(PSP)</td><td colspan="2">(DSP)</td><td colspan="2">(ASP)</td></tr><tr><td>Sampling Date</td><td>Multi SPR</td><td>ELISA</td><td>Multi SPR</td><td>ELISA</td><td>Multi SPR</td><td>ELISA</td></tr><tr><td>24.07.2011</td><td>−</td><td>−</td><td>−</td><td>−</td><td>−</td><td>−</td></tr><t... |
c690df1c0a2de9b761fc728c24fb97a20b350de386e2ce3e2fa042a7f37bbdbd.png | simple | <table><tr><td>Vitamin D Status</td><td>IOM</td><td>Endocrine Society</td></tr><tr><td>Deficiency</td><td><12 ng/mL (30 nmol/L)</td><td><20 ng/mL (50 nmol/L)</td></tr><tr><td>Insufficiency</td><td>12–20 ng/mL (30–50 nmol/L)</td><td>21–29 ng/mL (52.5–72.5 nmol/L)</td></tr><tr><td>Sufficienc... | <table><tr><td>Vitamin D Status</td><td>IOM</td><td>Endocrine Society</td></tr><tr><td>Deficiency</td><td><12 ng/mL (30 nmol/L)</td><td><20 ng/mL (50 nmol/L)</td></tr><tr><td>Insufficiency</td><td>12–20 ng/mL (30–50 nmol/L)</td><td>21–29 ng/mL (52.5–72.5 nmol/L)</td></tr></table> | <table><tr><td>Vitamin D Status</td><td>IOM</td><td>Endocrine Society</td></tr><tr><td>Sufficiency</td><td>>20 ng/mL (50 nmol/L)</td><td>>30 ng/mL (75 nmol/L)</td></tr><tr><td>Toxicity</td><td>>50 ng/mL (125 nmol/L)</td><td>>150 ng/mL (375 nmol/L)</td></tr></table> |
0005e8fe1b3ba14982336837219f285921af7c152cfc81ac88bcf52809299279.png | complex | <table><tr><td rowspan="2">Clinical characteristics</td><td colspan="3">Genotype</td><td rowspan="2">OR (95% C.I.)<sup>*</sup></td><td rowspan="2"><i>P</i></td><td colspan="2">Allele</td><td rowspan="2">OR (95% C.I.)</td><td rowspan="2"><i>P</i></td></tr><tr><td>TT</td><td>CT</td><td>CC</td><td>T</td><td>C</td></tr><tr... | <table><tr><td rowspan="2">Clinical characteristics</td><td colspan="3">Genotype</td><td rowspan="2">OR (95% C.I.)*</td><td rowspan="2">P</td><td colspan="2">Allele</td><td rowspan="2">OR (95% C.I.)</td><td rowspan="2">P</td></tr><tr><td>TT</td><td>CT</td><td>CC</td><td>T</td><td>C</td></tr><tr><td>Tumor size</td><td><... | <table><tr><td>4</td><td>85</td><td>80</td><td>15</td><td>1.31 (0.73-2.43)</td><td>0.363</td><td>250</td><td>110</td><td>1.19 (0.76-1.87)</td><td>0.425</td></tr><tr><td>Degree of differentiation</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Low</td><td>215</td><td>179... |
17b1f72a0aaf3b5443238bbe6389324f00c02a04168dae224efeea18fac6c7fc.png | simple | <table><tr><td></td><td>All</td><td>Gadopentetat (Magnevist)</td><td>Gadoteracid (Dotarem)</td><td>Gadobenat (Multihance)</td><td>Gadotbutrol (Gadovist)</td><td>Gadoteridol (Prohance)</td><td>Gadodiamide (Omniscan)</td><td>Other*</td></tr><tr><td>All</td><td>45</td><td>20</td><td>5</td><td>3</td><td>9</td><td>2</td><td... | <table><tr><td></td><td>All</td><td>Gadopentetat (Magnevist)</td><td>Gadoteracid (Dotarem)</td><td>Gadobenat (Multihance)</td><td>Gadotbutrol (Gadovist)</td><td>Gadoteridol (Prohance)</td><td>Gadodiamide (Omniscan)</td><td>Other*</td></tr><tr><td>All</td><td>45</td><td>20</td><td>5</td><td>3</td><td>9</td><td>2</td><td... | <table><tr><td>weats</td><td></td><td>2</td><td></td><td></td><td>1</td><td>0</td><td>0</td><td></td></tr><tr><td>Rash/Hives</td><td>15</td><td>4</td><td>4</td><td>2</td><td>2</td><td>2</td><td>1</td><td>0</td></tr><tr><td>Swelling of eye/face</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><t... |
8d887243df80d5643d8019667a0786dd3949bc7cbab9983b461c8a6849c937d2.png | simple | <table><tr><td>Gene Symbol</td><td>Primary Sertoli cell signal (normalized)</td><td>hS1 cell signal (normalized)</td><td>Log<sub>2</sub> FC (hS1 vs. Control)</td></tr><tr><td><i>GDNF</i></td><td>2.7378905</td><td>4.001061</td><td>1.2631705</td></tr><tr><td><i>BMP4</i></td><td>7.070616</td><td>10.179245</td><td>3.108629... | <table><tr><td>Gene Symbol</td><td>Primary Sertoli cell signal (normalized)</td><td>hS1 cell signal (normalized)</td><td>Log2 FC (hS1 vs. Control)</td></tr><tr><td>GDNF</td><td>2.7378905</td><td>4.001061</td><td>1.2631705</td></tr><tr><td>BMP4</td><td>7.070616</td><td>10.179245</td><td>3.108629</td></tr><tr><td>BMP6</t... | <table><tr><td>Gene Symbol</td><td>Primary Sertoli cell signal (normalized)</td><td>hS1 cell signal (normalized)</td><td>Log2 FC (hS1 vs. Control)</td></tr><tr><td>GATA4</td><td>10.017227</td><td>9.562365</td><td>–0.4548</td></tr><tr><td>GATA1</td><td>2.7784665</td><td>2.5375004</td><td>–0.2409661</td></tr></table> |
80c1018a35777848dcec6a97e478080b02d70e5f0deb7272d62b6fa5449364f4.png | complex | <table><tr><td><i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub>(M<sup>−1</sup> s<sup>−1</sup>)</td><td>C3</td><td>C5</td><td>C8</td><td>iso C5</td><td> </td></tr><tr><td>GEO179</td><td>0.9±0.02</td><td>100±15</td><td>1,200±130</td><td>41±1.2</td><td>Discovered</td></tr><tr><td>GEO195</td><td>... | <table><tr><td>kcat/KM(M−1 s−1)</td><td>C3</td><td>C5</td><td>C8</td><td>iso C5</td><td></td></tr><tr><td>GEO179</td><td>0.9±0.02</td><td>100±15</td><td>1,200±130</td><td>41±1.2</td><td>Discovered</td></tr><tr><td>GEO195</td><td>2.4±0.1</td><td>200±14</td><td>1,400±160</td><td>8±0.3</td><td>Discovered</td></tr><tr><td>... | <table><tr><td>1ZPD</td><td>46.7±1.4</td><td>0.95±0.02</td><td>0.021±0.001</td><td>n.d.</td><td></td></tr><tr><td>1OZF</td><td>n.d.</td><td>n.d.</td><td>n.d.</td><td>0.03±0.001</td><td></td></tr><tr><td>Native KIVD</td><td>n.d.</td><td>14.3±0.2</td><td>7±0.3</td><td>61±2.1</td><td></td></tr><tr><td>KIVD_VLV</td><td>n.d... |
d6dc032ecde98e1ba479e9ef8d89585ecbf6573e53fed1f76a12ca71d6c3b769.png | simple | <table><tr><td>No</td><td>Expression system</td><td>SAK Productivity [mg/L<sub>broth</sub>]</td><td>Cultivation system</td><td>Volume [L]</td><td>SAK - glycosylation [Yes/No]</td><td>Reference</td></tr><tr><td>1</td><td><i>E. coli</i></td><td>> 50</td><td>(not defined)</td><td>2.7</td><td>No</td><td>[8]</td></tr><tr... | <table><tr><td>No</td><td>Expression system</td><td>SAK Productivity [mg/Lbroth]</td><td>Cultivation system</td><td>Volume [L]</td><td>SAK - glycosylation [Yes/No]</td></tr><tr><td>1</td><td>E. coli</td><td>> 50</td><td>(not defined)</td><td>2.7</td><td>No</td></tr><tr><td>2</td><td>E. coli</td><td>> 175</td><td>Fermen... | <table><tr><td>Reference</td></tr><tr><td>[8]</td></tr><tr><td>[19]</td></tr><tr><td>[20]</td></tr><tr><td>[20]</td></tr><tr><td>[13]</td></tr><tr><td>[13]</td></tr><tr><td>[21]</td></tr><tr><td>[17]</td></tr><tr><td>[17]</td></tr><tr><td>-</td></tr></table> |
487fd8d72e9b0d583e0681ede7dad21030730e1f945c1862fa7523e21d5a17e3.png | simple | <table><tr><td>Length of training (months)</td><td>Total hours of training</td><td>Year</td></tr><tr><td>22</td><td>2996</td><td>1989</td></tr><tr><td>23</td><td>3672</td><td>1996</td></tr><tr><td>19.5</td><td>2719</td><td>2001</td></tr><tr><td>23</td><td>3341</td><td>2007</td></tr></table> | <table><tr><td>Length of training (months)</td><td>Total hours of training</td><td>Year</td></tr><tr><td>22</td><td>2996</td><td>1989</td></tr><tr><td>23</td><td>3672</td><td>1996</td></tr></table> | <table><tr><td>Length of training (months)</td><td>Total hours of training</td><td>Year</td></tr><tr><td>19.5</td><td>2719</td><td>2001</td></tr><tr><td>23</td><td>3341</td><td>2007</td></tr></table> |
0ea6c21d871a1d07268885ed36dfe8fb8524491e51fb35f98d2eab05dbe77333.png | complex | <table><tr><td>Provinces</td><td colspan="5">No. of samples</td></tr><tr><td></td><td>Bovine</td><td>Ovine</td><td>Caprine</td><td>Buffalo</td><td>Camel</td></tr><tr><td>Tehran</td><td>274</td><td>100</td><td>53</td><td>165</td><td>33</td></tr><tr><td>Isfahan</td><td>188</td><td>76</td><td>148</td><td>70</td><td>81</td... | <table><tr><td>Provinces</td><td colspan="3">No. of samples</td></tr><tr><td></td><td>Bovine</td><td>Ovine</td><td>Caprine</td></tr><tr><td>Tehran</td><td>274</td><td>100</td><td>53</td></tr><tr><td>Isfahan</td><td>188</td><td>76</td><td>148</td></tr><tr><td>Kerman</td><td>83</td><td>152</td><td>102</td></tr><tr><td>Kh... | <table><tr><td colspan="2">No. of samples</td></tr><tr><td>Buffalo</td><td>Camel</td></tr><tr><td>165</td><td>33</td></tr><tr><td>70</td><td>81</td></tr><tr><td>25</td><td>70</td></tr><tr><td>112</td><td>30</td></tr><tr><td>372</td><td>214</td></tr></table> |
12e64697310f3a65cf9256c1f7d4a4db86941baf72334fef358bf4f15df42570.png | simple | <table><tr><td>Number of strain/strain code</td><td>Species</td><td>Biofilm</td><td>Cefoxitin resistance</td></tr><tr><td>65/ MSSE 65</td><td><i>S.epidermidis</i></td><td>black (+)</td><td>S</td></tr><tr><td>62/ MRSE 62</td><td><i>S.epidermidis</i></td><td>black (+)</td><td>R</td></tr><tr><td>93/ MSSH 93</td><td><i>S.h... | <table><tr><td>Number of strain/strain code</td><td>Species</td><td>Biofilm</td><td>Cefoxitin resistance</td></tr><tr><td>65/ MSSE 65</td><td>S.epidermidis</td><td>black (+)</td><td>S</td></tr><tr><td>62/ MRSE 62</td><td>S.epidermidis</td><td>black (+)</td><td>R</td></tr><tr><td>93/ MSSH 93</td><td>S.haemolyticus</td><... | <table><tr><td>Number of strain/strain code</td><td>Species</td><td>Biofilm</td><td>Cefoxitin resistance</td></tr><tr><td></td><td>us</td><td>deaux (−)</td><td></td></tr><tr><td>ATCC 12493</td><td>S. aureus</td><td>very black (+)</td><td>R</td></tr></table> |
504565b2e9f9b8aa441dd6dba7621f70efdafd06a61609cca9cf3a5722415cde.png | simple | <table><tr><td>Country</td><td>Seroprevalence of HCV in general population [1, 63] (%)</td><td>Seroprevalence<sup>a</sup> of HCV in HIV patients (%)</td></tr><tr><td>Argentina</td><td>1.9</td><td>29.9</td></tr><tr><td>Brazil</td><td>1.4</td><td>18.9</td></tr><tr><td>Chile</td><td>0.8</td><td>2.6</td></tr><tr><td>Colomb... | <table><tr><td>Country</td><td>Seroprevalence of HCV in general population [1, 63] (%)</td><td>Seroprevalencea of HCV in HIV patients (%)</td></tr><tr><td>Argentina</td><td>1.9</td><td>29.9</td></tr><tr><td>Brazil</td><td>1.4</td><td>18.9</td></tr><tr><td>Chile</td><td>0.8</td><td>2.6</td></tr></table> | <table><tr><td>Country</td><td>Seroprevalence of HCV in general population [1, 63] (%)</td><td>Seroprevalencea of HCV in HIV patients (%)</td></tr><tr><td>Colombia</td><td>1.0</td><td>0.8</td></tr><tr><td>Cuba</td><td>1.8</td><td>12.9</td></tr><tr><td>Mexico</td><td>1.0</td><td>12.1</td></tr><tr><td>Peru</td><td>1.0</t... |
5bb678d39f5d5c3dd1d4637096d0a5902645b7b5b6580a5f2c370b50714a936c.png | simple | <table><tr><td>Variable</td><td>AQP4(−) NEBLs patients (n=16)</td><td>AQP4(+) NEBLs patients (n=37)</td><td>P values</td></tr><tr><td>Serum analysis</td><td> </td><td> </td><td> </td></tr><tr><td> CRP (mg/l)</td><td>1.81 ± 0.65</td><td>3.01 ± 1.01</td><td>0.371</td></tr><tr><td> ESR (mm/H)</td><td>17.19... | <table><tr><td>Variable</td><td>AQP4(−) NEBLs patients (n=16)</td><td>AQP4(+) NEBLs patients (n=37)</td><td>P values</td></tr></table> | <table><tr><td>Serum analysis</td><td></td><td></td><td></td></tr><tr><td>CRP (mg/l)</td><td>1.81 ± 0.65</td><td>3.01 ± 1.01</td><td>0.371</td></tr><tr><td>ESR (mm/H)</td><td>17.19 ± 2.22</td><td>15.24 ± 12.24</td><td>0.57</td></tr><tr><td>C3 (g/l)</td><td>1.16 ± 0.20</td><td>1.14 ± 0.30</td><td>0.838</td></tr><tr><td>... |
50325c499138132b3cdcb62e4edd12647ee74afb576479bc35b8648d30b5e553.png | complex | <table><tr><td>Person Characteristics</td><td>SfW N = 314</td><td>Control N = 59</td><td><i>P-</i>Values</td></tr><tr><td>Female patients, n (%)</td><td>180 (57.3)</td><td>30 (50.8)</td><td><i>0.3574</i></td></tr><tr><td>Age<sup>a</sup>, yrs, (± SD)</td><td>41.2 (± 11.97)</td><td>39.9 (± 12.55)</td><td><... | <table><tr><td>Person Characteristics</td><td>SfW N = 314</td><td>Control N = 59</td><td>P-Values</td></tr><tr><td>Female patients, n (%)</td><td>180 (57.3)</td><td>30 (50.8)</td><td>0.3574</td></tr><tr><td>Agea, yrs, (± SD)</td><td>41.2 (± 11.97)</td><td>39.9 (± 12.55)</td><td>0.4532</td></tr><tr><td>Weighta, kg, (± S... | <table><tr><td>15D total score a, (± SD)</td><td>0.814 (± 0.12)</td><td>0.857(± 0.09)</td><td>0.0085*</td></tr><tr><td>SWN total score a, (± SD)</td><td>80.5 (± 15.97</td><td>87.9 (± 18.35)</td><td>0.0016*</td></tr><tr><td colspan="4">Clinical Characteristics</td></tr><tr><td>Psychiatric Diagnosis</td><td></td><td></td... |
62c42963ac3d31cd4d5eed53cad2a6643903139c580af982dc5f807249e891d3.png | complex | <table><tr><td></td><td colspan="2">Group</td></tr><tr><td></td><td>STZ + DMH</td><td>STZ + DMH + MET</td></tr><tr><td><i>N</i></td><td>13</td><td>15</td></tr><tr><td>Tumor-bearing rats</td><td>11</td><td>9</td></tr><tr><td>Tumor incidence (%)</td><td>84.62</td><td>60.00</td></tr><tr><td>Number of tumors</td><td>40</td... | <table><tr><td></td><td colspan="2">Group</td></tr><tr><td></td><td>STZ + DMH</td><td>STZ + DMH + MET</td></tr><tr><td>N</td><td>13</td><td>15</td></tr><tr><td>Tumor-bearing rats</td><td>11</td><td>9</td></tr><tr><td>Tumor incidence (%)</td><td>84.62</td><td>60.00</td></tr><tr><td>Number of tumors</td><td>40</td><td>20... | <table><tr><td>Average tumor number of tumor-bearing rats</td><td>3.6 ± 0.28</td><td>2.2 ± 0.36*</td></tr><tr><td>Volume of tumors (mm3)</td><td>94.8 ± 19.77</td><td>30.9 ± 8.19*</td></tr><tr><td>Inhibition of colorectal tumor (%)</td><td></td><td>29.08</td></tr></table> |
b38c61fb9c95b436f1d5b6462cc34db2b630074edc8139f5f90f0b0f445b6076.png | simple | <table><tr><td>Study design</td><td>Study</td><td>Comment</td></tr><tr><td>Survey</td><td>National TB epidemiological survey 2002<sup>17</sup></td><td>45% (121/272) of patients having interrupted or suspended treatment due to financial difficulty</td></tr><tr><td></td><td>Zhang 2007<sup>12</sup></td><td>9% of household... | <table><tr><td>Study design</td></tr><tr><td>Survey</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Cohort</td></tr><tr><td></td></tr></table> | <table><tr><td>Study</td><td>Comment</td></tr><tr><td>National TB epidemiological survey 200217</td><td>45% (121/272) of patients having interrupted or suspended treatment due to financial difficulty</td></tr><tr><td>Zhang 200712</td><td>9% of households with TB suspects (2308) or patients defaulted due to financial bu... |
d5f31047919c3397268b1b8677b6c1a282d8141ba6e1492c2ec2541bda4d8540.png | simple | <table><tr><td></td><td>Control</td><td>NASH</td><td>HFD</td><td>HFr</td></tr><tr><td>Liver weight (g)</td><td>18.9 ± 3.4<sup>#</sup></td><td>32.7 ± 7.9*<sup>†‡</sup></td><td>16.5 ± 2.5<sup># ‡</sup></td><td>23.1 ± 4.4<sup>#†</sup></td></tr><tr><td>Fasting plasma glucose (mM)... | <table><tr><td></td><td>Control</td><td>NASH</td></tr><tr><td>Liver weight (g)</td><td>18.9 ± 3.4#</td><td>32.7 ± 7.9*†‡</td></tr><tr><td>Fasting plasma glucose (mM)b</td><td>6.4 ± 0.2#†‡</td><td>7.2 ± 0.2*</td></tr><tr><td>Fasting plasma insulin (pM)b</td><td>560.6 ± 79.5</td><td>486.7 ± 93.7</td></tr><tr><td>Plasma β... | <table><tr><td>HFD</td><td>HFr</td></tr><tr><td>16.5 ± 2.5# ‡</td><td>23.1 ± 4.4#†</td></tr><tr><td>7.5 ± 0.1*</td><td>7.16 ± 0.2*</td></tr><tr><td>603.0 ± 43.7</td><td>695.8 ± 83.7</td></tr><tr><td>115.4 ± 16.8*#‡</td><td>38.4 ± 2.8†</td></tr><tr><td>9366.6 ± 2052.8*#‡</td><td>2638.0 ± 808.5†</td></tr><tr><td>1.5 ± 0.... |
1ae8376e039296ca0b09ebeefa8fa8bee8d07940507c66f7f03e5054d94fea75.png | simple | <table><tr><td>Study</td><td>Year published</td><td>n</td><td>MC/SC</td><td>Patients</td><td>EN/PN</td><td>Gln adm</td><td>Daily gln dose</td><td>Length of treatment*</td><td>Treatment benefit</td></tr><tr><td>Andrews [53]</td><td>2011</td><td>502</td><td>MC</td><td>General ICU</td><td>EN+PN</td><td>iv</td><td>10-20 g<... | <table><tr><td>Study</td><td>Year published</td><td>n</td><td>MC/SC</td><td>Patients</td><td>EN/PN</td><td>Gln adm</td><td>Daily gln dose</td><td>Length of treatment*</td><td>Treatment benefit</td></tr><tr><td>Andrews [53]</td><td>2011</td><td>502</td><td>MC</td><td>General ICU</td><td>EN+PN</td><td>iv</td><td>10-20 g<... | <table><tr><td>Study</td><td>Year published</td><td>n</td><td>MC/SC</td><td>Patients</td><td>EN/PN</td><td>Gln adm</td><td>Daily gln dose</td><td>Length of treatment*</td><td>Treatment benefit</td></tr><tr><td>Jones [49]</td><td>1999</td><td>50</td><td>SC</td><td>General ICU</td><td>EN</td><td>enteral</td><td>18 (11-21... |
19d7a9281d88859755a67da31df6038783db4ad8ab1144623a664343f5eadfb8.png | complex | <table><tr><td></td><td colspan="4">Timing of initial post-discharge outpatient follow up</td></tr><tr><td></td><td>Casesn</td><td>≤3 daysn (%)</td><td>>3 daysn (%)</td><td>p-value</td></tr><tr><td colspan="5">Low-risk*</td></tr><tr><td> Short-stay†</td><td>34</td><td>22 (65)</td><td>12 (35)</td><td rows... | <table><tr><td></td><td colspan="4">Timing of initial post-discharge outpatient follow up</td></tr><tr><td></td><td>Casesn</td><td>≤3 daysn (%)</td><td>>3 daysn (%)</td><td>p-value</td></tr><tr><td colspan="5">Low-risk*</td></tr><tr><td>Short-stay†</td><td>34</td><td>22 (65)</td><td>12 (35)</td><td>0.29</td></tr></tabl... | <table><tr><td></td><td colspan="4">Timing of initial post-discharge outpatient follow up</td></tr><tr><td></td><td>Casesn</td><td>≤3 daysn (%)</td><td>>3 daysn (%)</td><td>p-value</td></tr><tr><td>Longer-stay</td><td>44</td><td>22 (50)</td><td>22 (50)</td><td>0.29</td></tr><tr><td colspan="5">Higher-risk</td></tr><tr>... |
a8b95d60eb82d7ccf08b2be4b8c64e1c3eed8fda81ab5c4dae491aff5e281ac8.png | simple | <table><tr><td>Nomenclature</td><td>Amino acids</td><td>Chromosome</td><td>Intracellular localization</td></tr><tr><td>Zm2G012631_T01</td><td>699</td><td>II</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><td>Zm2G112165_T01</td><td>698</td><td>II</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><... | <table><tr><td>Nomenclature</td><td>Amino acids</td><td>Chromosome</td><td>Intracellular localization</td></tr><tr><td>Zm2G012631_T01</td><td>699</td><td>II</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><td>Zm2G112165_T01</td><td>698</td><td>II</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><... | <table><tr><td>Nomenclature</td><td>Amino acids</td><td>Chromosome</td><td>Intracellular localization</td></tr><tr><td>Zm5G833699_T01</td><td>714</td><td>V</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><td>Zm2G141931_T01</td><td>804</td><td>II</td><td>Endoplasmic reticulum and vacuole</td></tr><tr><td>Zm2... |
8154aa3fed550650fbbc16c8bf1092f584e16afada77c098ad1ef73a2896fdf4.png | complex | <table><tr><td>Clinical and laboratory parameters</td><td></td><td colspan="5">Pharmacokinetic parameters <sup>1,2</sup>(number of data points)</td></tr><tr><td></td><td><i>K</i><sub>β</sub></td><td><i>T</i><sub>1/2β</sub></td><td>MRT<sub>iv</sub></td><td>CL<sub>CEF</sub></td><td><i>V</i><sub><i>β</i></s... | <table><tr><td>Clinical and laboratory parameters</td><td></td><td colspan="5">Pharmacokinetic parameters 1,2(number of data points)</td></tr><tr><td></td><td>Kβ</td><td>T1/2β</td><td>MRTiv</td><td>CLCEF</td><td>Vβ</td><td>VSS</td></tr><tr><td>Weight</td><td>0.08</td><td>-0.05</td><td>-0.04</td><td>-0.34</td><td>-0.42*... | <table><tr><td>Albumin</td><td>0.63*</td><td>-0.31</td><td>-0.32</td><td>0.21</td><td>-0.27</td><td>-0.43**</td></tr><tr><td></td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td></tr><tr><td>Hemoglobin</td><td>0.07</td><td>0.06</td><td>0.07</td><td>-0.42**</td><td>-0.58**</td><td>-0.59**</... |
ea306aada0d37430acfbce0dd525b17bdd8e2447ba9ce114721230f55d970746.png | complex | <table><tr><td rowspan="3">Age, years</td><td rowspan="3"><i>N</i></td><td colspan="7">Point prevalence of SRH</td></tr><tr><td>Fine(excellent, very good,or good)</td><td>Excellent</td><td>Very good</td><td>Good</td><td>Fair</td><td>Poor</td><td>Invalid response</td></tr><tr><td colspan="9">Men</td></tr><tr><td>20̵... | <table><tr><td rowspan="3">Age, years</td><td rowspan="3">N</td><td colspan="2">Point prevalence of SRH</td></tr><tr><td>Fine(excellent, very good,or good)</td><td>Excellent</td></tr><tr><td colspan="2"></td></tr><tr><td colspan="4">Men</td></tr><tr><td>20–29</td><td>51</td><td>92%</td><td>33%</td></tr><tr><td>30–39</t... | <table><tr><td colspan="5">Point prevalence of SRH</td></tr><tr><td>Very good</td><td>Good</td><td>Fair</td><td>Poor</td><td>Invalid response</td></tr><tr><td colspan="5"></td></tr><tr><td colspan="5">Men</td></tr><tr><td>12%</td><td>47%</td><td>6%</td><td>0%</td><td>2%</td></tr><tr><td>21%</td><td>42%</td><td>8%</td><... |
4e21ccfa28d26fa705d00a0a306d1969d17f05015f9011af27c5f9d4d05b7c40.png | complex | <table><tr><td>Compartment</td><td colspan="6">Local<sup>**</sup></td><td colspan="6">Distant<sup>**</sup></td></tr><tr><td></td><td>sp<sup>†</sup></td><td>sh<sup>†</sup>°</td><td>cb</td><td>ais</td><td>?</td><td>n (∑)</td><td>sp<sup>†</sup></td><td>sh<sup>†</sup>°</td><td>cb<sup... | <table><tr><td>Compartment</td><td colspan="6">Local**</td><td colspan="6">Distant**</td></tr><tr><td></td><td>sp†</td><td>sh†°</td><td>cb</td><td>ais</td><td>?</td><td>n (∑)</td><td>sp†</td><td>sh†°</td><td>cb^</td><td>ais</td><td>?</td><td>n (∑)</td></tr></table> | <table><tr><td>Abs. N°</td><td>22</td><td>47</td><td>0</td><td>0</td><td>5</td><td>74</td><td>15</td><td>56</td><td>3</td><td>0</td><td>5</td><td>79</td></tr><tr><td>%</td><td>29.7</td><td>63.5</td><td>0.0</td><td>0.0</td><td>6.8</td><td>(100)</td><td>19.0</td><td>70.9</td><td>3.8</td><td>0.0</td><td>6.3</td><td>(100)<... |
137472339b0bcf8d560835e52dada0873874413d04b41a1c34bf1a5caba8d888.png | simple | <table><tr><td>cDNA</td><td>No. of isolates</td><td>Characteristics</td></tr><tr><td>NIK</td><td>58</td><td>N terminal deletion</td></tr><tr><td>CD30</td><td>3</td><td>Full length</td></tr><tr><td>LT-βR</td><td>2</td><td>Cytoplasmic region</td></tr><tr><td>RIP2</td><td>1</td><td>Full length</td></tr></table> | <table><tr><td>cDNA</td><td>No. of isolates</td><td>Characteristics</td></tr></table> | <table><tr><td>NIK</td><td>58</td><td>N terminal deletion</td></tr><tr><td>CD30</td><td>3</td><td>Full length</td></tr><tr><td>LT-βR</td><td>2</td><td>Cytoplasmic region</td></tr><tr><td>RIP2</td><td>1</td><td>Full length</td></tr></table> |
7d1aa2f1cf12662900dfcf304eb5657e365b2965c88cd580a13a0441e98ee509.png | complex | <table><tr><td></td><td colspan="3">Cardiac syncope vs non-cardiac syncope<i>n =</i> 142</td><td colspan="3">Cardiac syncope vs chest pain control group<i>n =</i> 147</td></tr><tr><td>Patient characteristics</td><td>Cardiac syncope<i>n = 49</i></td><td>Non-cardiacsyncope<i>n = 93</i></td><td><i>P</i>-value</td><td>Card... | <table><tr><td></td><td colspan="3">Cardiac syncope vs non-cardiac syncopen = 142</td><td colspan="3">Cardiac syncope vs chest pain control groupn = 147</td></tr><tr><td>Patient characteristics</td><td>Cardiac syncopen = 49</td><td>Non-cardiacsyncopen = 93</td><td>P-value</td><td>Cardiac syncopen = 49</td><td>Chest pai... | <table><tr><td>Age, years</td><td>60 ± 13</td><td>54 ± 12</td><td>0.002</td><td>60 ± 13</td><td>60 ± 12</td><td>0.810</td></tr><tr><td>Male gender</td><td>32 (65)</td><td>57 (61)</td><td>0.716</td><td>32 (65)</td><td>64 (65)</td><td>>0.999</td></tr><tr><td>BMI, kg/m2</td><td>26 ± 3</td><td>26 ± 4</td><td>0.365</td><td>... |
bf2f11c3fe8a0aaa0082fa482305f537d13f90574faf8f4e13c4870afba8d816.png | simple | <table><tr><td>Sample</td><td>pH</td><td>Temp (°C)</td><td>Conductivity (μS cm<sup>−1</sup>)</td><td>dO<sub>2</sub> (%)</td><td>TSS (mg L<sup>−1</sup>)</td><td>PO<sub>4</sub> (μM)</td><td>NH<sub>4</sub> (μM)</td><td>NO<sub>2</sub> + NO<sub>3</sub> (μM)</td><td>Partic P (μM)</td... | <table><tr><td>Sample</td><td>pH</td><td>Temp (°C)</td><td>Conductivity (μS cm−1)</td><td>dO2 (%)</td><td>TSS (mg L−1)</td><td>PO4 (μM)</td><td>NH4 (μM)</td><td>NO2 + NO3 (μM)</td><td>Partic P (μM)</td><td>Rainfall (mm)</td><td>V rich</td></tr><tr><td>6-3_0830</td><td>7.19</td><td>21.4</td><td>479.2</td><td>23.5</td><t... | <table><tr><td>Sample</td><td>pH</td><td>Temp (°C)</td><td>Conductivity (μS cm−1)</td><td>dO2 (%)</td><td>TSS (mg L−1)</td><td>PO4 (μM)</td><td>NH4 (μM)</td><td>NO2 + NO3 (μM)</td><td>Partic P (μM)</td><td>Rainfall (mm)</td><td>V rich</td></tr><tr><td>6-7_0930</td><td>6.10</td><td>21.9</td><td>109.8</td><td>77.0</td><t... |
c29f8f2d0b4975bc2e587d1c2f1367f1ca658e1f5391c45d9cd80a6f0f104b68.png | complex | <table><tr><td>Main mindfulness instruction</td><td>General guidance points</td><td>Contemplative movement</td><td>Mindful movement</td></tr><tr><td>Awareness of sensations</td><td>Bodily sensations as objects for the attention (sensations related to autonomic response, skeletal and muscular aspects, pressure, tactile ... | <table><tr><td>Main mindfulness instruction</td><td>General guidance points</td><td>Contemplative movement</td><td>Mindful movement</td></tr><tr><td>Awareness of sensations</td><td>Bodily sensations as objects for the attention (sensations related to autonomic response, skeletal and muscular aspects, pressure, tactile ... | <table><tr><td>Main mindfulness instruction</td><td>General guidance points</td><td>Contemplative movement</td><td>Mindful movement</td></tr><tr><td>Awareness of intention (on purpose)</td><td>Purposeful, deliberate engagement with the intention to move the body, pay attention, be present, mindful</td><td>Can be (e.g.,... |
8daaa9901c5060289bcf1f6bff7996da46e946d2b0c480e13bb5e98a491b220f.png | complex | <table><tr><td>Markers</td><td colspan="3">Markers in the DG</td><td colspan="2">Markers in the SVZ</td></tr><tr><td></td><td>Ki67</td><td>DCX</td><td>Prox1</td><td>SOX2</td><td>Dlx2</td></tr><tr><td rowspan="2">BrdU</td><td>-</td><td><i>F</i><sub>(1,5)</sub> = 11.2, <i>r</i> = 0.83 <i>p</i> = 0.020 (AIE, P57)</td><td>... | <table><tr><td>Markers</td><td colspan="2">Markers in the DG</td></tr><tr><td></td><td>Ki67</td><td>DCX</td></tr><tr><td rowspan="2">BrdU</td><td>-</td><td>F(1,5) = 11.2, r = 0.83 p = 0.020 (AIE, P57)</td></tr><tr><td></td><td>-</td></tr><tr><td></td><td></td><td>p = 0.020 (AIE, P95)</td></tr><tr><td>SOX2</td><td>F(1,5... | <table><tr><td>Markers in the DG</td><td colspan="2">Markers in the SVZ</td><td rowspan="3"></td></tr><tr><td>Prox1</td><td>SOX2</td><td>Dlx2</td></tr><tr><td>-</td><td>-</td><td>F(1,5) = 9.9, r = 0.82 p = 0.025 (Control, P95)</td></tr><tr><td>F(1,6) = 10.0, r = 0.79</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td>... |
01b79b27aad9485b9b4adcc71c7eaae0caa45cd15bf550004ed86ac544ee95ac.png | simple | <table><tr><td> Compounds of hydrocarbon</td><td>Mean</td><td>SD</td></tr><tr><td>Pars 1 dispersant</td><td>0.126</td><td>0.082</td></tr><tr><td> Pars 2 dispersant</td><td>0.055</td><td>0.049</td></tr><tr><td> Gamlen dispersant</td><td>0.011</td><td>0.004</td></tr><tr><td> Crude oil</td><td>0.072</td><td> 0.046</td></t... | <table><tr><td>Compounds of hydrocarbon</td><td>Mean</td><td>SD</td></tr><tr><td>Pars 1 dispersant</td><td>0.126</td><td>0.082</td></tr><tr><td>Pars 2 dispersant</td><td>0.055</td><td>0.049</td></tr><tr><td>Gamlen dispersant</td><td>0.011</td><td>0.004</td></tr><tr><td>Crude</td><td>0.07</td><td>0.0</td></tr></table> | <table><tr><td> oil</td><td>2</td><td>46</td></tr><tr><td>Pars 1 dispersant + petroleum</td><td>0.156</td><td>0.098</td></tr><tr><td>Pars 2 dispersant + petroleum</td><td>0.104</td><td>0.087</td></tr><tr><td>Gamlen dispersant + petroleum</td><td>0.115</td><td>0.067</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.